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Abstract
This project was concerned with the synthesis of nanoparticles (NPs) by microfluidics from
bulk ginseng polysaccharides (PS) isolated from American ginseng to design a new
delivery system to improve the bioavailability of PS. Physicochemical analyses showed
products of nanosizing as unimodal spheres with a diameter of ~19 nm. Pharmacological
characterization studies in vitro of these nanoparticles of PS (NPPS) have demonstrated
heightened immunostimulatory activity, and enhanced penetration across skin cell
monolayer, which could be considered as evidence of increased bioavailability. Studies
using PS sub-fractions with different molecular weights for NPPS synthesis showed that
molecular weights is one of the parameters that influence the quality of NPPS. Mechanistic
study revealed that NPPS acted like PS in targeting the Toll-like receptor-signalling
pathway in mediating the immune-stimulatory effect. This nanotechnology may be applied
to produce innovative ginseng polysaccharide-based nutraceuticals with improved
bioavailability.

Keywords:

American

nanoparticles,

ginseng,

microfluidics,

Panax

quinquefolius,

nanoprecipitation,

ginseng

macrophages,

polysaccharides,
physicochemical

characterization, monolayer model, transport, immunostimulation, molecular weight, TLR
signalling

i

Co-Authorship Statement

Dr. Edmund M.K. Lui and Dr. Paul A. Charpentier supervised and contributed to the design
of all the experiments. Farida Akhter greatly helped with the synthesis and characterization
of ginseng polysaccharide nanoparticles.

ii

Acknowledgements

I would like to extend my deepest gratitude to my supervisors Dr. Edmund M.K. Lui and
Dr. Paul A. Charpentier for providing me the opportunity to work on this project. The
amount of aid and knowledge I have received during this project is immeasurable and will
prove to be useful in all walks of life.

I would also like to acknowledge the members of my advisory committee Dr. Lina
Dagnino, Dr. Thomas Drysdale and Dr. Qingping Feng for their priceless guidance and
continuous support throughout the course of my MSc research.
This project would not have been possible if not for the help from Dr. Paul A. Charpentier’s
lab, their guidance in the synthesis and operation of the experiments and sharing of
resources.
Special thanks to Dr. Dixon’s lab from whom some of our cells were obtained from, their
sharing of their equipment, and the helpful advice and knowledge.

I would also like to thank the staff of the Department of Physiology and Pharmacology at
the University of Western Ontario for their help and time. This thesis would not have been
made possible if not for the support of family and friends. I would like to express my
appreciation to Virginia Lee and Gina Zhu for their boundless aid, care, and support.

I would also like to acknowledge the funding support received from Mitacs Accelerate and
Western Phytoceutica. This project would have not been possible without their support.

iii

Table of Contents
Abstract

i

Co-Authorship Statement

ii

Acknowledgements

iii

Table of Contents

iv

List of Figures

vii

List of Abbreviations

ix

Chapter 1

1

General Introduction, Literature Review and Research Hypotheses

1

1.1

Relevance of medicinal plants in modern medicine

2

1.2

Ginseng

3

1.2.1

Historical background ................................................................................................... 3

1.2.2 Bioactive constituents of ginseng ............................................................................... 4
1.3

Plant Polysaccharides

5

1.3.1 Chemical structure of ginseng polysaccharides ...................................................... 5
1.3.2 Chromatography, detection and quantitative analysis of PS ............................. 7
1.3.3 Extraction and isolation of plant polysaccharides ............................................... 7
1.3.4 Immunomodulatory and antioxidant effects of plant polysaccharides ......... 8
1.4

Innate immunity

11

1.4.1 Immunomodulation ...................................................................................................... 11
1.4.2 Macrophage-mediated innate immunity ............................................................. 12
1.4.3 Lipopolysaccharides (LPS) ......................................................................................... 14
1.4.4 Ginseng PS-mediated activation of TLR signalling.............................................. 16
1.5

Nanomaterials

17

1.5.1 Nanomedicine for topical administration ............................................................. 18
1.5.2 Epidermal drug transport ............................................................................................. 19
1.5.3 Synthesis of nanoparticles.......................................................................................... 19
1.6 Summary and Rationale

21

1.7 Hypothesis and Aims

22

1.8 References

24

iv

Chapter 2

35

Synthesis and characterization of physicochemical and biological properties of
nanoparticles prepared from American ginseng polysaccharides

35

2.1 Introduction

36

2.2 Experimental Procedure

39

2.2.1 Materials .............................................................................................................................. 39
2.2.2 Preparation of ginseng PS ............................................................................................. 39
2.2.3 Physicochemical characterization of ginseng PS nanoparticles .................... 42
2.2.4 Biological analyses........................................................................................................... 43
2.2.5 Statistical analysis ............................................................................................................ 47
2.3 Results and discussion

47

2.3.1 Morphology and size distribution of ginseng PS and NPPS ............................. 47
2.3.2 Biological characterization of NPPS......................................................................... 52
2.3.2.1 Stimulation of macrophage function. ................................................................. 52
2.3.2.2 Penetration of NPPS across keratinocyte monolayer model in vitro. ...... 54
2.3.3 Effect of substrate molecular weight on nanonization..................................... 61
2.4 Conclusions

67

2.5 Acknowledgments

68

2.6 References

69

Chapter 3

73

Mechanism of macrophage stimulation in vitro by American ginseng
polysaccharides nanoparticles

73

3.1 Introduction

74

3.2 Experimental Procedure

76

3.2.1 Materials .............................................................................................................................. 76
3.2.2 Macrophage cell culture and marker of activation ............................................. 77
3.2.3 Time-course of immunostimulation ......................................................................... 77
3.2.4 Effect of TLR desensitization by LPS pre-treatment .......................................... 78
3.2.5 Effect of pre-treatment with a selective inhibitor of TLR 2/4 (Sparstolonin
B) ....................................................................................................................................................... 78
3.2.6 Statistical analysis............................................................................................................ 78
3.3 Results and Discussion

79
v

3.3.1 Time-course of immunostimulatory effect of PS and NPPS in
macrophages in vitro ................................................................................................................. 79
3.3.2 Immunostimulatory effects of NPPS in LPS-desensitized macrophages in
vitro .................................................................................................................................................. 80
3.3.3 TLR 2/4 antagonist suppressed NPPS activity ..................................................... 82
3.4 Conclusions

85

3.5 Acknowledgments

86

3.6 References

87

Chapter 4

91

Conclusions and Recommendations

91

4.1 Summary and conclusions

92

4.2 Challenges and solutions

93

4.3 Future studies

94

Appendices

96

vi

List of Figures
Figure 1.1. Chemical structure of ginseng polysaccharides36. ........................................... 6
Figure 1.2. Droplet formation using different microfluidic junction geometry (a) crossjunction and (b) T-junction. ....................................................................................... 21
Figure 2.1. Schematic illustration of ultracentrifuge filtration procedure for separation of
ginseng polysaccharides by nominal molecular weight limit (NWML). .................. 41
Figure 2.2. Experimental setup of continuous microfluidics system for the preparation of
ginseng polysaccharide nanoparticles. ...................................................................... 42
Figure 2.3. Schematic of penetration model. HaCaT keratinocyte monolayers were
cultured on 1 µM transwell inserts (polyethylene terephthalate). ............................. 45
Figure 2.4. Transmission electron microscopy (TEM) of (a) ginseng PS and (b) NPPS. 49
Figure 2.5. Size distribution of ginseng NPPS prepared by nanoprecipitation using
microfluidics. ............................................................................................................. 50
Figure 2.6. Dynamic Light Scattering of (a) ginseng PS and (b) ginseng NPPS using
Zetasizer Nanosizer. .................................................................................................. 51
Figure 2.7. Immunostimulatory effects of ginseng PS and NPPS on macrophage NO
production. ................................................................................................................. 53
Figure 2.8. Accumulation of ginseng PS and NPPS across keratinocyte monolayer over
periodic intervals. ...................................................................................................... 57
Figure 2.9. Basolateral concentration of PS and NPPS after 24-hour treatment. ............ 58
Figure 2.10. (i) Transmission electron microscopy (TEM) and (ii) size distribution of
NPPS prepared using (a) 30-50 kDa, (b) 50-100 kDa and (c) >100 kDa
ultracentrifuged PS fractions. .................................................................................... 63
Figure 2.11. Immunostimulatory effects of (i) ginseng PS and (ii) NPPS on the production
of NO by macrophages after 24 hours. Three molecular weight fractions were used:
(a) 30-50 kDa (S), (b) 50-100 kDa (M) or (c) >100 kDa fractions (L). .................... 67

vii

Figure 3.1. Immunostimulatory effects of ginseng PS and NPPS on macrophage nitrite
production. ................................................................................................................. 79
Figure 3.2. Immunostimulatory effects of ginseng PS and NPPS on macrophage NO
production. ................................................................................................................. 81
Figure 3.3. Immunostimulatory effects of ginseng PS and NPPS on macrophage NO
production over a 24-hour period. ............................................................................. 83

viii

List of Abbreviations
A

uronic acid

Araf

arabinofuranose

AUC

area under the curve

BMBM

bone-marrow-derived macrophages

BPI

bactericidal/permeability increasing protein

C2H/HeJ

TLR4 deficient mice

CD14

cluster of differentiation 14

CR3
COX-2

complement receptor-3
cyclooxygenase-2

DAMPs

damage-associated molecular patterns

DLS

dynamic light scattering

DMEM

Dulbecco’s Modified Eagle’s Medium

EDTA

ethylenediaminetetraacetic acid

ELISA

enzyme-linked immunosorbent assay

ELSD

evaporative light scattering detector

FBS

fetal bovine serum

FTIR

Fourier-transform infrared spectroscopy

Gal

galactose

GBE

ginseng berry extract

Glc

glucose

H2O2

hydrogen peroxide

HaCaT

spontaneously transformed aneuploid immortal keratinocyte cell line

hCMEC/D3
HPLC

human cerebral microvascular endothelial cells
high-performance liquid chromatography

IFNγ

interferon gamma

IgM

immunoglobulin M

IKK

inhibitor of nuclear factor kappa-B kinase

IκBα

inhibitor of kappa B

IL

interleukin

iNOS

inducible nitric oxide synthase
ix

IRAK

IL-1R-associated kinase

IRF

interferon regulatory transcription factor

ITAM

immunoreceptor tyrosine-based activation motif

LBP

lipid binding protein

LPS

lipopolysaccharides

LRR

leucine-rich repeat domain

Man

mannose

MAPK

mitogen-activated protein kinases

mCD14

Membrane-bound CD14

MD-2

myeloid differentiation factor-2

MyD88

myeloid differentiation primary response 88

NF-κB

nuclear factor-kappa-light-chain-enhancer of activated B cells

NHPs

natural health products

NK

natural killer

NMWL

nominal molecular weight limit

NO

nitric oxide

NPPS

nanoparticle of ginseng polysaccharides

PAMPs

pattern-associated molecular pattern

PET

polyethylene terephthalate

PGE2

prostaglandin E2

PI3K

phosphatidylinositol 3-kinase

PRR

pattern recognition receptor

PS

polysaccharides

RANKL

receptor activator of nuclear kappa-B ligand

RAW 264.7

macrophage; Abelson murine leukemia virus transformed

Rha

rhamnose

RI

refractive index

sCD14

soluble CD14

SR
SsnB

scavenger receptor
Sparstolonin B

TCM

Traditional Chinese Medicine

x

TEER

transepithelial electrical resistance

TEM

transmission electron microscopy

TiO2

titanium dioxide

TIR

toll-interleukin 1 receptor

TIRAP

TIR-domain-containing adaptor protein

TLR

toll-like receptor

TNFα

tumor necrosis factor alpha

TRAF6

TNF receptor-associated factor 6

TRAM

TRIF-related adaptor molecule

TRIF

TIR-domain-containing adaptor-inducing interferon-β

UV

ultraviolet

UV/Vis

Ultraviolet/Visible

WHO

World Health Organization

XRD

X-ray diffraction

ZnO

zinc oxide

xi

Chapter 1
General Introduction, Literature Review and
Research Hypotheses

1

1.1

Relevance of medicinal plants in modern medicine

Throughout history, medicinal plants have been used to treat common ailments, alleviate
discomfort, prevent infection, maintain wellness and restore health1–3. A medicinal plant
is defined as a plant which contains one or more bioactive compounds in any part(s) of the
plant that can be used for therapeutic purposes or as precursors for the development of
drugs. These bioactive compounds (i.e., phytochemicals) include alkaloids, flavonoids,
tannins, saponins, phenolics, terpenoids, and carbohydrates, to name a few4. The discovery
of a plant’s medicinal value was often accidental, through observation or trial and error.
The development of herbalism relied heavily on oral tradition to pass down centuries of
knowledge until the advent of writing and record keeping. Herbal knowledge differs
geographically due to regional ecozones. In some cultures, herbal medicine has developed
into relatively more advanced systems referred to as traditional medicines. Traditional
Chinese, Native American, African, and East Indian Ayurvedic medicine are such
examples.

Within North America, it is estimated that ~70% of Canadians regularly take natural health
products (NHPs) in the management of their health5. Under the Natural Health Products
Regulations (Canada), NHPs include: “vitamins and minerals, herbal remedies,
homeopathic medicines, traditional medicines such as Traditional Chinese Medicines,
probiotics and other products like amino acids and essential fatty acids”6. These NHPs are
regulated under the Natural and Non-prescription Health Products Directorate. In Canada,
a 2011 Functional Foods and Natural Health Products survey reported revenues of $11.3
billion, with exports of $1.7 billion and $238 million going into research and development7.

It is a common misconception that the entirety of a traditional medicine system is a pseudomedicine or placebo-medicine. Although there are such cases, including homeopathy,
traditional medicine systems contain many medicinal plants which have been identified to
contain bioactive compound(s)1. The bark of the Pacific Yew is one Native American
example which has been researched and developed into Taxol - a chemotherapeutic8.
Traditionally, it was used to treat several complaints ranging from gastrointestinal to
respiratory ailments. In the 1960s, Taxol was isolated from the Pacific Yew and reported
2

to exhibit anti-tumor properties8. Further research validated its potential as an anti-tumor
compound and by 1979, it was reported by Schiff et al. that the compound was an antimitotic agent that promotes microtubule stability, thereby inhibiting cell growth by halting
cell division and ultimately resulting in cell death9. Recently, artemisinin from sweet
wormwood (Artemisia annua) and its derivatives have been used to treat malaria10. It has
been traditionally used for dyspepsia, appetite loss and biliary dyskinesia11. Artemisinin
combination therapy has been estimated to have averted ~146 million clinical cases during
2000 – 201510. Other well-known examples include acetylsalicylic acid from Salix spp.,
atropine from cocaine from Erythroxylim coca, digitoxin from Digitalis purpurea,
ephedrine from Ephedra sinica, galanthamine from Leucojum aestivum, morphine from
Papaver somniferum, quinine from Cinchona ledgeriana, and, vincristrine or vinblastine
from Catharantus roseus1.

Application of ethnobotany to pharmacology has classically been utilized to bridge
naturally occurring substances to treat various diseases and conditions12. Medicinal plants
that have been traditionally used for the treatment of certain illnesses can be screened for
potential bioactive compounds12. However, some medicinal plants contain multiple
bioactive components that act synergistically on different targets13. Thus, making it
difficult to screen for a specific compound.

1.2
1.2.1

Ginseng
Historical background

Ginseng is a deciduous perennial herb part of the Araliaceae family within genus Panax
and is found in Asia (Panax ginseng) and North America (Panax quinquefolius)14. Various
other species of ginseng have also been identified in around 11 other regions such as Panax
notoginseng, Panax trifolius or Panax vietnamensis, to name a few14. The genus Panax
originates from the Greek word “panaxos’ which literally translates into “cure all” or “allhealing”14. The species ginseng originates from the Chinese characters “rénshēn”, meaning
“person-herb” since the shape of the root is similar to the shape of a human2. Ginseng3

derived products are often referred to as adaptogens, which are non-toxic and non-specific
(i.e., global/ broad effects) substances thought to increase physiological resistance to
biological stress. The term ‘adaptogen’ was first introduced in the late 1940s; however,
adaptogenic effects are not well received by the public due to the lack of research behind
its non-specific benefits.

Ginseng has been historically used in Traditional Chinese Medicine (TCM). In TCM,
normal body function is described to be controlled by a balance of Yin and Yang, the two
opposite but complementary forces. Moreover, foods and medicinal plants are classified
according to their natural properties, such as temperature characteristics (hot, warm,
neutral, cool and cold); and these properties could impact on the Yin –Yang balance. It is
believed that unwellness or illness occurs when there is a Yin – Yang imbalance of Yin
and Yang, and that sickness can be resolved through rebalancing. Historically, Panax
ginseng (Asian ginseng) is described to have ‘warm’ properties, whereas Panax
quinquefolius (American ginseng) is described as having ‘cool’ properties. Prior to its
introduction and trade to Asia, American ginseng was used in Traditional Native American
medicine to relieve cold sore, fever, and gastrointestinal distress15.
1.2.2 Bioactive constituents of ginseng
Ginseng contains many bioactive compounds include ginsenosides, polysaccharides,
peptides, triterpenoids, flavonoids, polyacetylenic alcohols, essential oils, fatty acids and
antioxidants16,17. These compounds are present in all ginseng species with a degree of
variation18,19. The diverse range of bioactive compounds present in ginseng could explain
why it has been traditionally utilized to treat or alleviate the symptoms of a broad range of
illnesses and ailments2,15,19. Recent research has reported that ginseng exhibits
immunostimulatory, immunosuppressive, anti-mutagenic, anti-tumor, anti-oxidative, and
hypoglycemic effects20–23. In particular, the pro-inflammatory effects of ginseng have been
mainly attributed to polysaccharides20. Beneficial effects on halting or slowing the
progression of atherosclerosis, osteoporosis, arthritis, depression or diabetic complications
have also been reported in the literature24–28.
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1.3

Plant Polysaccharides

Plant polysaccharides (PS) are macromolecules made up of long chains of
monosaccharides linked together by glycosidic bonds (Fig 1.1)29. In general, plant cells
contain mainly starches, pectins, cellulose and hemicellulose. Starches are glucans
composed of α-(1,4)-glycosidic linkages (i.e., amylose) and may contain α-(1,6)-glycosidic
linked branches along the main chain (i.e., amylopectin)30. These PS are found in the
amyloplasts of plant cells and are the main glucose storage component of plants. Pectins
are also composed of α-(1,4)-glycosidic bonds and maybe branched30. Pectic
polysaccharides are high in galacturonans and may exist as homopolysaccharides or
heteropolysaccharides30. They are found in the middle lamella and within the plant cell
wall, and function as a structural component. Cellulose is composed of unbranched glucans
with

β-(1,4)-glycosidic

bonds30.

In

contrast,

hemicellulose

is

branched

heteropolysaccharides composed of α- and β-glycosidic linkages31. Cellulose and
hemicellulose are located in the plant cell wall and function as a structural component.

Polysaccharides are recognized as biological polymers due to the high degree of variation
in the number and type of repeating monomers, conformation, functional groups and
degree of branching. PS are heterogeneous with wide molecular weight distribution
because of the broad differences in structure between individual PS30. The differences in
structure also lead to variation in solublity30. Aside from the type of glycosidic bonds
present in PS, the main repeating monosaccharide unit(s) determines the subtype of PS
(e.g., pectin: type II rhamnogalacturonan). In general, plant PS are hydrophilic due to the
presence of multiple hydroxyl groups30. However, they become more hydrophobic with an
increasing number of internal hydrogen bonds30. PS with more intramolecular hydrogen
bonding interact less with water decreasing its hydration30.
1.3.1 Chemical structure of ginseng polysaccharides
Plant PS isolated from ginseng are structural and soluble PS that originate from the plant
cell walls. They mainly consist of starch-like PS, pectin PS and hemicellulose31. As
aforementioned, the structure of the PS differs greatly between individual PS. Starch-like
5

PS mainly contains branched α-(1,6)-glucans, α-(1,2)-glucans and α-(1,3)-glucans32. Pectic
PS are primarily rich in homogalacturonans with a molar ratio of up to 70% and a small
degree of branching33. They are composed of rhamnose (Rha), arabinose (Araf), galactose
(Gal), glucose (Glc) and uronic acid (A) (1:4:8:8:50)33. A minority of ginseng pectic PS
has been identified as type 1 rhamnogalacturonans33. Guo et al. demonstrated that these
pectic PS exhibit similarity to several citrus pectins33. The main sugar residue of these
pectins is 4-α-D-GalA and other residues like 2-α-L-Rha, 2-4-α-L-Rha, α-L-Araf, β-D-Gal
and 4-β-D-Gal33. Recently, ginseng hemicellulose has been shown to predominantly
consist of β-glycosylic-linked xylans, xyloglucans and glucomannans31. In addition to the
different types of ginseng PS, individual PS may have a different number of monomeric
repeats. The diversity and complexity of PS result in the heterogeneity of ginseng PS. In
particular, the molecular weight of ginseng PS can range from as low as 3.1 kDa to as high
as 2,000 kDa34,35.
Ginseng PS are also broadly separated into two categories: acidic and neutral PS31. Acidic
PS contains Gal, Rha, Ara, Glc and mannose (Man) that are high in GalA and GlcA31,36.
These acidic PS are generally pectins30. Neutral PS includes starch-like glucans that are
high in Ara and Gal and lack carboxyl functional groups31,32.

Figure 1.1. Partial chemical structure of ginseng polysaccharides29.
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1.3.2 Chromatography, detection and quantitative analysis of PS
The analysis of plant polysaccharides is a challenge due to low UV/Vis
(Ultraviolet/Visible) absorbance and high complexity. As such, quantitation based on
UV/Vis absorbance such as High Performance Liquid Chromatography (HPLC) using a
UV/Vis detector is unsuitable37. HPLC using a Refractive Index (RI) detector is also
unsuitable to analyze PS due to problems with sensitivity37. HPLC-RI is often performed
on homogenous solutions; however, PS are highly complex and heterogeneous which
would result in a broad range of RI values. Baseline stability is also a concern when using
HPLC-RI for PS because any changes to the eluent composition would require reequilibration of the detector. Evaporative Light Scattering Detector (ELSD) has been
previously used to analyze PS composition because it can detect compounds which are less
volatile than the mobile phase rather than detecting optical properties37. Despite the
benefits of this analytical technique, the quantification of PS concentration is still a
problem. Plant PS lack chromophoric moieties, therefore, labelling PS with a fluorescent
tag would allow for the detection of PS molecules38. Concentration can be quantified with
the use of a fluorometer, but this technique is limited by the selectivity of labelling, which
has yet to be addressed. Alternatively, it is possible to quantify plant PS by conducting a
biological assay and calculating concentration from a preconstructed standard curve. A
sensitive assay, such as Griess’ assay to detect nitric oxide (NO) or enzyme-linked
immunosorbent assay (ELISA) to detect interleukin (IL)-6 or tumor necrosis factor alpha
(TNFα) could be used to build this standard curve.
1.3.3 Extraction and isolation of plant polysaccharides
Ginseng PS are typically extracted and isolated from the plant biomass through hot-water
extraction followed by precipitation of PS with alcohol. The precipitate can be further
purified to yield deproteinated PS (i.e., bulk PS). Briefly, a methodology to extract PS from
North American ginseng roots was developed by Professor Lui and Charpentier’s group at
Western University, Canada. First, ground-up ginseng roots were soaked in water at 40 °C
for 5 hours to yield a water-soluble extract. The extract was then concentrated to remove
excess solvent and lyophilized to obtain a dry aqueous extract. To isolate PS, the dried
aqueous extract was dissolved in distilled water at a known concentration and four
7

equivalent volumes of 95% ethanol were added to the aqueous solution and lyophilized to
obtain the powdered PS extract. The water-soluble PS extract was be furthered processed
to remove proteins and yield the deproteinated water-soluble PS extract.
1.3.4 Immunomodulatory and antioxidant effects of plant polysaccharides
The effects of PS vary depending on their origin and composition. Generally, plant PS are
immunostimulatory and act primarily on macrophages and circulating monocytes. Other
effects including immunosuppressive, antimicrobial and antioxidant activities have also
been reported20,39. Various plant PS have been recently demonstrated to elicit these effects
in vitro and in vivo. For example, PS isolated from Sargassum fusiforme, a brown sea
vegetable, have been reported to stimulate peritoneal macrophages through toll-likereceptor (TLR) 2 or TLR4 pathway via P38 mitogen-activated protein kinases (MAPK)40.
The proliferation of splenic lymphocytes and immunoglobulin M (IgM) expression were
both enhanced in cells treated with these PS. In another study, Sargassum fusiform PS
stimulated TNFα, IL-1 and IL-6 production in RAW 264.7 (Abelson mouse leukemia virus
transformed) macrophages41. This was mediated by NF-κB signalling via the cluster of
differentiation 14 (CD14)/ inhibitor of nuclear factor kappa-B kinase (IKK) and p38
MAPK pathway41. Similarly, PS isolated from a heart-leaved moonseed, Tinospora
cordifolia, have been shown to upregulate TNFα, IL-1β, IL-6, IL-12 and interferon-gamma
(IFNγ) in RAW 264.7 macrophages and peritoneal macrophages42. Non-starch PS high in
galacturonic acid has also been shown to increase NO, TNF-α and IL-6 production in
macrophages (RAW 264.7) through the TLR4 pathway43. These non-starch PS were
isolated from Dioscorea polystachya (Chinese Yam). PS isolated from fungi such as
Grifola frondosa (Hen-of-the-wood) have demonstrated similar effects44. Murine
macrophages (RAW 264.7) treated with these PS-induced morphological changes,
increased IL-1β, IL-10 and NO production44.

Ma et al. recently reported dose-dependent antioxidant effects exhibited by red onion
(Allium cepa) PS that were sequentially extracted using hot buffer, chelating agent, dilute
alkali and concentrated alkali39. The authors demonstrated that the degree of radical
scavenging, iron chelating, lipid peroxidation inhibition and reducing power was
8

influenced by the PS composition39. The monosaccharide composition of these four PS
fractions was previously shown to be different from each other45. Using the same
extraction methodology, PS extracted from mulberry leaves (Morus alba) also exhibited
dose-dependent antioxidant effects. Likewise, the degree of antioxidant activity was
dependent on monosaccharide composition46. Interestingly, the antioxidant activity of
plant PS can be enhanced through hydroxyl modifications. Li et al. showed the antioxidant
activity of PS extracted from peony seed dreg (sediments) can be positively altered by
sulfation, phosphorylation or carboxyl methylation47.

1.3.4.1 Biological effects of ginseng polysaccharides.
Ginseng PS exhibit a broad range of biological effects and have been widely reported for
their immunomodulatory and antioxidant properties. In a study investigating the
immunomodulatory effects of ginseng PS in murine peritoneal macrophages, PS isolated
from a ginseng extraction by-product enhanced hydrogen peroxide (H2O2) and NO
production48. Lim et al. reported that PS-treated macrophages had stimulated lysosomal
phosphatase and phagocytic activities48. Sun et al. recently found enhanced natural killer
(NK) cell cytotoxicity in PS-treated immunosuppressed mice, specifically via the
upregulation of perforin and granzyme49. Similarly, Azike et al. reported that PS treatments
exerted immunostimulatory effects on macrophages20. IL-6, TNFα and NO were
upregulated in a dose-dependent manner20. The authors also showed that pre-treating
murine macrophages with PS-induced attenuation of immune response20. Azike et al. also
found that the potency of PS was positively correlated to its molecular weight range50.

The immunostimulatory activity of the PS is also related to their type, such as acidic or
neutral PS. It was previously shown that the bioactive species of PS were mainly acidic
and not neutral PS37. In one study, rat alveolar macrophages did not respond significantly
to treatment with neutral PS but responded to acidic PS37. Pretreatment of macrophages
with neutral PS resulted in minimal immunosuppressive effects in LPS-stimulated
macrophages37. In a recent study, a novel neutral PS (3.1 kDa) isolated from North
American ginseng and was reported to have significant anti-inflammatory activity35. Yu et
al. demonstrated that acidic PS were more immunostimulatory compared to neutral PS 51.
9

In addition, neutral PS were found to be less immunostimulatory than crude PS isolate51.
Shin et al. showed that acidic ginseng PS stimulated immune cells and upregulated the
production of TNFα, IL-6, IL-1β and IFNγ52. Similarly, Park et al. investigated the
immunomodulatory effects of acidic PS extracted from Panax ginseng53. Their study
revealed that acidic PS-treated mice had higher levels of inducible nitric oxide synthase
(iNOS) production compared to the control mice53. Moreover, the addition of an iNOS
inhibitor (i.e., aminoguanidine) along with acidic PS attenuated the PS-mediated- immune
suppression in sheep red blood cells53. The authors also showed that macrophages treated
with acidic PS have increased cytotoxic activity53. In particular, elevated NO and H2O2
production and increased phagocytic activity were measured53.

Pectin-like PS exhibited similar immunostimulatory effects as glucans. For example,
increased proliferation of splenocytes and activation of peritoneal exudate macrophages
and NK cells were reported in pectin-treated mice54. Recently, a novel pectin-like PS
extracted in the presence of ethylenediaminetetraacetic acid (EDTA) was demonstrated to
stimulate T and B lymphocyte proliferation55.

1.3.4.2 Ginseng-polysaccharides-derived natural health products.
Several products containing ginseng PS have been marketed and approved by Health
Canada; however, many do not have substantial research on their efficacy and safety for
consumption. Of note, CVT-E002 (i.e., COLD-FX®) claims to help reduce the frequency,
severity and duration of cold and flu symptoms by boosting the immune system56. CVTE002 is a North American Ginseng PS extract which has been demonstrated to reduce
eosinophilic airway inflammation in asthma-induced mice57. Adamko et al. also found that
CVT-E002 reduced airway reactivity57. Moreover, CVT-E002 stimulated proliferation of
murine B lymphocytes and production of NO, TNFα, IL-1 and IL-6 in peritoneal exudate
macrophages58. In addition, an elevation in immunoglobulin G (IgG) production was
observed in mice treated with CVT-E00258. These results have been recently replicated by
Song et al. who reported that immunosuppressed mice treated with CVT-E002 increased T
and B lymphocyte proliferation and, NK cell activity59. Another recent publication reported
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that CVT-E002 stimulated the proliferation of T and B cells and production of IL-10 and
IL-6 in mice60.

1.4

Innate immunity

The non-specific immune response of the host to foreign substances (i.e., antigens) and
microorganisms such as viruses, bacteria, protozoa and fungi are the initial line of defense
against infection. The first aspect of innate immunity is physical and chemical barriers
(e.g., epidermis, intestinal epithelium, saliva, bile, stomach acid, etc.) which prevent or
limit exposure to foreign materials and cells. Cellular and molecular components present
in the tissues and circulatory system such as dendritic cells, NK cells, mast cells and
phagocytes, as well as complements or inflammatory mediators are another aspect of innate
immunity61,62. The former is involved in the capture and elimination of pathogens,
particles, cellular debris or infected cells61. Complements and inflammatory mediators are
responsible for the enhancement of phagocytic activity via opsonization and the
recruitment and activation of phagocytes, respectively62. Other components of the innate
immune system include neutrophils, granulocytes (basophils and eosinophils), and
cytokines. Granulocytes produce bactericidal proteins, reactive oxygen species, histamine,
as well as cytokines that help regulate cells involved in the innate immune response. A
crucial function of the innate immune system involves downstream activation of adaptive
immunity61,63. The adaptive or acquired immune response involves the activation of T and
B lymphocytes via antigen presentation by innate immune cells and the production of
memory cells and antibodies targeting specific antigens63.
1.4.1 Immunomodulation
Immunomodulation refers to the regulation of the immune system by exogenous or
endogenous compounds including those that originate from biological stress.
Immunomodulatory compounds (i.e., immunomodulators or biological response
modifiers) might act to elicit proinflammatory or anti-inflammatory responses through the
innate immune system. Some compounds, such as plant PS, can both stimulate and inhibit
various immune responses35,58. In general, plant PS are known to stimulate immune cells
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via TLR signalling40,43. Such compounds that can stimulate specific aspects of innate
immunity are known as immune-stimulants. On the other hand, compounds capable of
inhibiting specific aspects of the host immune response are referred to as immunoinhibitors. Immuno-suppressors are compounds that can attenuate host immune response
which may occur through a variety of pathways, such as receptor desensitization or via
inhibition of responses64,65. The goal of desensitization is the attenuation of subsequent
innate immune responses. For example, desensitization of TLRs in macrophages following
stimulation by a TLR agonist leads to the reduced presence of cell-surface TLRs. This
attenuates immunostimulatory responsiveness to subsequent treatment with TLR agonists.

1.4.2

Macrophage-mediated innate immunity

Macrophages are mononuclear phagocytic leukocytes that are present in tissues and in the
circulatory system. Those in the blood are referred to as monocytes and are differentiated
from tissue macrophages. Overall, the functions of macrophages include both the direct
phagocytosis of foreign material or cellular debris as well as the indirect secretion of
inflammatory mediators such as TNFα and IL-666. Macrophages also play a role in
presenting antigens to helper T-cells and are essential in promoting wound closure and
tissue repair63,66. Macrophages within different tissues exhibit varying morphologies and
functions which are niche-specific and tissue-specific. For instance, skin-resident
macrophages (i.e. Langerhans cells) are very heterogeneous in morphology and are widely
distributed throughout the tissue to act as first responders to potential pathogen invasions67.
Other examples of tissue-specific macrophages are Kupffer cells in the liver, microglia in
the central nervous system, dust cells in the lung, osteoclasts in the bone, sinus histiocytes
in the lymph nodes and adipose tissue macrophages in body fat.

It was long-believed that macrophages were classically activated by cytokines IFNγ and
TNFα produced by helper T-cells or alternatively activated by regulatory T cell-released
IL-1066. While it remains true that macrophages polarize toward one phenotype in response
to specific signals and are associated with different functions, research in the past decade
has led to a paradigm shift in our understanding of the activation of macrophages and the
12

requirement of T-cells. In light of this, macrophages are classified into two general groups,
M1 and M2 macrophages, based on their response or activation/polarization by specific
stimuli66,68,69. The two groups represent two sides on a linear scale. M1 macrophages lean
towards the ‘inhibit’ or ‘kill’ function, whereas M2 macrophages lean towards the ‘healing’
or ‘repair’ function69,70. M1 macrophages that were previously known as the classically
activated macrophages are activated by pathogen associated molecular patterns (PAMPs),
damage-associated molecular patterns (DAMPs), TNFα or IFNγ70,71. These macrophages
are mainly pro-inflammatory and phagocytic which produce high levels of IL-12 and low
levels of IL-1068. On the other hand, M2 macrophages, previously known as alternatively
activated macrophages, are activated by inflammatory mediators such as glucocorticoids,
IL-4, IL-10, IL-13 or prostaglandins66,72,73. Collectively, these stimuli are referred to as M2
stimuli and the response is mainly anti-inflammatory. M2 is further sub-grouped into M2a,
M2b, M2c and M2d depending on the stimuli or response. In general, M2 macrophages are
involved in wound healing, allergy regulation and Th2 responses, and produce higher
levels of IL-10 compared to M1 macrophages68,69,74. In addition, M2 macrophages are
thought to be the basal phenotype of tissue-resident macrophages70. They are not activated
into M2 macrophages, but rather present as M2-like or M2-deactivated macrophages under
basal conditions. Alternatively, these macrophages are referred to as unprimed or naïve
macrophages (M0)75. In the absence of external physical stress, resident macrophages
remove cellular debris and senescent cells. Resident macrophages can quickly develop into
the M1 phenotype or stay as M2 depending on the stimuli; however, the response of
resident macrophages is tissue-specific and niche-specific69,70. During wound-healing, the
less inflammatory M2 macrophages are the predominant phenotype, and M2-type
responses are modulated69,70. They promote tissue formation and inflammation resolution
through the release of growth factors and phagocytosis of apoptotic neutrophils69,76.

Macrophage cell lines such as RAW 264.7 or bone-marrow derived macrophages (BMDM)
are naïve or unprimed (i.e., M0) macrophages and can be polarized to M1 or M2
phenotype75. RAW 264.7 cell line – which was used in this study – are
monocyte/macrophage-like cells established from ascites of a tumor induced by Abselon
Leukaemia Virus in BALB/c mice. They have been described as an appropriate model of
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macrophages and can be polarized to M1 or M2 via IFNγ or IL-4, respectively77,78. In
addition, RAW 264.7 cells can be differentiated into osteoclasts with RANKL (receptor
activated NF-kappa B ligand)79. Compared to other cell lines, RAW 264.7 cells are
morphologically unique (elongated; projections). Although its phenotypic and functional
stability was initially described by ATCC to lose stability after passage 18, a recent paper
recommends the use of up to passage 3077.

1.4.3 Lipopolysaccharides (LPS)
M1 macrophages are activated in response to PAMPs which are derived from bacteria and
other foreign microorganisms68,70. PAMPs are recognized by pattern recognition receptors
(PRR) on the macrophages70. Endotoxin or bacterial lipopolysaccharide (LPS) is a wellreported PAMP originating from the outer monolayer of the outer membrane of gramnegative bacteria80. LPS binds to cell-surface TLRs which are a class of pattern recognition
receptors (PRRs) found in phagocytes such as neutrophils, macrophages and dendritic
cells80. LPS are made up of a lipid A and polysaccharide portion80. The polysaccharide
portion has three regions: O-antigen, outer core and inner core80. Lipid A is a glucosaminebased phospholipid and its main function is to enhance the outer membrane stability80. The
toxicity level of LPS is mainly attributed to its lipid A region. The O-antigen region is not
essential for TLR4 binding; however, LPS that lack an O-antigen region (i.e., rough LPS)
does not require the help of lipid binding protein (LBP) and CD1481,82. Both forms of LPS
are highly toxic and can elicit a response from macrophages and monocytes even at a
concentration as low as 10 – 500 pg/mL for LPS83. Overall, excessive TLR signalling by
LPS binding results in fever, hypotension and eventually septic shock that leads to
widespread organ failure.

The binding of LPS to TLRs is enhanced by LBP, a soluble protein. LBP non-covalently
binds LPS and delivers LPS to cluster of differentiation 14 (CD14) or TLRs82. The
interaction of LBP and CD14 with LPS forms a ternary complex 82. The ternary complex
facilitates the transfer of monomeric LPS to TLR4/myeloid differentiation factor-2 (MD2) complex82. MD-2 is co-expressed with TLR4, which is vital for the TLR4 response to
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LPS as well as the recognition of lipoteichoic acid from gram-positive bacteria84. Aside
from presenting LPS to the TLR4 complex, CD14 mediates translocation of the TLR4
complex to an endosome85. Therefore, CD14 is essential for early and late phase (i.e.,
endosomal) TLR4-signalling.

1.4.3.1 Toll-like receptor (TLR) 4 signaling
TLR4 signalling is activated upon ligand recognition by the leucine-rich repeat domain
(LRR) of the TLR4 and dimerization of the TLR4/MD-2/ligand complex via the LRR
domain86. Dimerization of the TLR4/MD-2/ligand complex enables dimerization of the
intracellular toll-interleukin 1 receptor (TIR)-domain of TLR486. Subsequently,
intracellular TLR4 adaptor proteins, which contain TIR-domains, are recruited to the TIRdomain of TLR487. These adaptor proteins include TIR-domain-containing adaptor protein
(TIRAP), TRIF (TIR-domain-containing adaptor-inducing interferon-β), TRAM (TRIFrelated adaptor molecule) and MyD88 (myeloid differentiation primary response 88).
There are two pathways in TLR4 signalling: MyD88-dependent and TRIF-dependent
pathway.

1.4.3.2 MyD88-dependent signalling.
In the MyD88-dependent signalling, TIRAP is recruited to TLR4 and binds to the TIR
domain of TLR4 through its TIR domain88. Upon recruitment, TIRAP facilitates MyD88
recruitment to TLR4 via indirect binding (i.e., bridging)88. Recruitment of MyD88 results
in downstream activation of TNF receptor-associated factor 6 (TRAF6) via IL-1Rassociated kinase (IRAK)1/289. This leads to the downstream activation of IKK complex,
which in turn phosphorylates inhibitor of kappa B (IκBα) and targets it for degradation 90.
Subsequently, NF-κB (nuclear factor-kappa-light-chain-enhancer of activated B cells)
translocates to the nucleus and binds to promoters target genes including iNOS/NOS2,
Cyclooxygenase-2 (PTGS2/COX-2), TNFα and IL-6, to name a few91,92. COX-2 and iNOS
mediate the production of prostaglandin E2 (PGE2) and NO, respectively.

15

1.4.3.3 TRIF-dependent signalling.
Following LPS binding, TLR4 complex is internalized into an endosome in a dynamindependent-manner65. The translocation of TLR4 to endosomes is a prerequisite for TRIFdependent signalling93. The internalization of the TLR4 complex prevents subsequent
activation of the MyD88-dependent pathway by TLR4 agonists94. TRIF-dependent
signalling begins with the recruitment of TRAM to the TIR-domain of TLR495. Similar to
TIRAP and MyD88, TRAM recruits and bridges TRIF to TLR4 at the TIR-domain95.
Following association, TRIF binds to TRAF6 which in turn downstream activates NF-κB
resulting in late-phase NF-κB pathway93,95.

1.4.4 Ginseng PS-mediated activation of TLR signalling
Ginseng exhibits both immunostimulatory and anti-inflammatory effects. The opposing
immunological effects have been attributed to the constituent PS and ginsenosides,
respectively20. However, ginseng PS has also been reported to have anti-inflammatory and
immunosuppressive effects35,96. Ginseng PS upregulated NO, IL-1β, IL-6, IFN-γ, and
TNFα production in macrophages through TLR4 signalling52. Studies revealed that ginseng
PS modulate immune response through NF-κB, p38 MAPK, MAPK1/3 and PI3K
(phosphatidylinositol 3-kinase) cascades97. In addition, the expression of CD14 proteins in
macrophages was increased after treatment with acidic PS from Asian ginseng52. LPS has
been known to act through TLR4 signalling and it was reported that macrophages
stimulated with LPS exhibited enhanced CD14 expression98. Thus, the upregulation of
CD14 expression by acidic PS may suggest its involvement in the activation of TLR
signalling by PS. Moreover, the production of TNFα, IL-1β, IL-6, IFNγ were impaired in
TLR4 deficient mice (C2H/HeJ) treated with ginseng radix extract99.
Ginseng PS exhibited immunosuppressive effects in LPS-induced models100. McElhaney
et al. reported that CVT-E002TM suppressed activation of neutrophils and production of
inflammatory cytokines (i.e., IL-2, IFNγ) in spleen cells induced by LPS stimulation100.
Similarly, Zhao et al. reported that ginseng PS reduced the expression of TNFα and IFNγ
in intraepithelial lymphocytes and lamina propria lymphocytes in collagen-induced
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arthritis rats101. Acidic PS isolated from Asian ginseng exhibited suppressive effects in a
model of demyelinating disease, experimental autoimmune encephalomyelitis102. The
extract inhibited autoreactive T-cell proliferation and proinflammatory cytokine (i.e.,
IFNγ, IL1β and IL-17) production, thereby reducing the progression of autoimmune
encephalomyelitis102. Furthermore, the extract activated FoxP3 transcription factor which
is a regulator of regulatory T-cells102.

The immunosuppressive or protective effects observed with ginseng PS are likely due to
endotoxin-tolerance

and

negative

regulation

of

downstream

pro-inflammatory

responses96,103. Internalization of TLR4 is characteristic of endotoxin-tolerant immune
cells94,98. The translocation of TLR4 into endosomes has been reported to be regulated by
CD14 mediated by immunoreceptor tyrosine-based activation motif (ITAM)85. Subsequent
stimulation of endotoxin-tolerant immune cells with PAMPs (e.g., LPS) may result in a
reduced immunostimulatory response. Compared to LPS, ginseng PS are non-toxic, lacks
the lipid A moiety and is markedly less potent29,50. Therefore, the activation of TLR4
signalling by ginseng PS via CD14 is likely to result in the internalization of TLR4
mediated by ITAM52,85. This might explain one aspect of the protective effects of ginseng
PS found in the literature.

1.5

Nanomaterials

Nanoparticles are defined as particles with at least one dimension less than 1000 nm but
greater than 1 nm in diameter; however, they are commonly less than 100 nm. They exhibit
different physicochemical properties than the substrate (i.e., bulk material) used to
synthesize them such as solubility, permeability or particle size. In particular, the decrease
in particle size from its corresponding bulk compound has been shown to enhance its
uptake by cells (e.g., epithelial cells within the gastrointestinal tract)104. The application of
nanotechnology to pharmacological agents has provided many benefits, removed various
pre-existing inconveniences or minimized side-effects; however, the toxicity of
nanomaterials remains highly controversial. This is because the fate of nanoparticles differs
depending on its physicochemical characteristics and some of which have not been clearly
identified105,106.
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There are many characteristics of nanoparticles that are desirable in pharmaceutical
compounds such as smaller particle size, improved solubility and dissolution or different
release characteristics (e.g., pH), to name a few104,107–109. Moreover, substrate toxicity can
be mitigated by encapsulation or surface modifications106,110. In general, the larger surfacearea-to-volume ratio promotes greater molecular interactions and ultimately greater
cellular uptake111. Change in surface chemistry and enhancement of drug solubility can
also increase the drug bioavailability109,112,113. Common examples include enhancing the
lipophilicity of a drug or encapsulating a drug to protect it from degradation and
metabolism prior to reaching its site of action. Targeted drug delivery via surface
functionalization is another approach used to address some of the predominant issues in
the field114. For example, albumin can reversibly bind to a drug (e.g., Paclitaxel) to
facilitate its transport across the endothelium via glycoprotein 60-mediated transcytosis115.
Drugs could also be modified with marker-attached polymers (e.g., conjugated antibodies)
to target its delivery to specific organs/tissues116. The nanoparticle itself can also function
as a therapeutic agent (e.g., nanocrystals, PS NPs) with enhanced transport and reduced
crystalline/hydrodynamic size38,104.
1.5.1 Nanomedicine for topical administration
The majority of nanotechnology applications to drugs have been directed to orally
administered drugs with low bioavailability or widespread toxic side effects. Thus far,
relatively few compounds have been synthesized into nanoparticles for topically
administered compounds. Many of these are skin care products such as pain relief,
antiseptics, first-aid compounds, scar treatments, acne creams, anti-aging treatments and
hydration products. For example, nanoparticles of zinc oxide (ZnO) and titanium dioxide
(TiO2) offer a broader range of UV protection than their microparticle counterparts117,118.
For physical agents like sunscreens, nanoparticles offer greater transparency as opacity is
aesthetically unappealing. Nanotechnology has also been applied in the design of skin
cancer drugs for enhanced accumulation in tumor tissue and improved potency119.
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1.5.2 Epidermal drug transport
Most topically administered drugs require penetration into or across the epidermal layer to
elicit their pharmacological effect. Thus, the epidermis is present as a physical barrier to
these drugs. The epidermis consists of keratinocytes that are differentiated and organized
into the stratum corneum at the superficial layer, followed by the stratum granulosum,
stratum spinosum and stratum basale. The stratum corneum functions as the main barrier
against physical trauma, chemical and pathogenic attack, as well as ultraviolet (UV)
irradiation. In addition, a non-polar lipid barrier formed by lamellar bodies in keratinocytes
is present at the level of the stratum granulosum67. In the stratum spinosum, keratinocytes
are connected together by a large number of desmosomes67. Macrophages (i.e., Langerhans
cells) are also resident to the stratum spinosum67. The stratum basale consists of both
quiescent and actively proliferating basal keratinocytes that form a monolayer where
individual cells are connected through tight junctions and are attached to the basement
membrane67,120.

Transport of drugs across the skin can occur via the paracellular or transcellular, or transappendageal pathway. The polarity and size of molecules are important for bypassing the
lipid matrix or plasma membrane of keratinocytes and ultimately affects its route of
transport121. The transport across other cell barriers such as the intestinal epithelium may
occur by paracellular or transcellular pathways. For skin, paracellular transport involves
movement through the lipid matrix in intercellular spaces of keratinocytes. Sufficiently
small particles (< 500 Da) can also be transported paracellularly across tight junctions of
keratinocytes120,121. Particles which typically undergo this passive process are
hydrophilic122. In general, particulates that are < 500 nm are transported transcellularly
through clathrin-mediated, caveolae-mediated or non-specific endocytosis whereas large
particulates are phagocytosed123. In addition, molecules with a large surface area to volume
ratio have higher uptake into cells due to greater interaction with membrane receptors124,125.
1.5.3 Synthesis of nanoparticles
In general, there are two approaches to synthesizing nanomaterials: top-down (i.e. bulk
material/ substrate to nanoparticles) and bottom-up (i.e. nanomaterial from atomic or
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molecular species through chemical reactions)104,126. There are various methodologies to
synthesize nanomaterials such as nanoprecipitation, microemulsion, nanocrystallization,
nano-lithography, and milling with their own associated advantages and disadvantages.
There are also more specialized derivatives of the aforementioned approaches. For
example, variations of nanoprecipitation include open-microfluidics, continuous-flow
microfluidics and digital microfluidics38,127,128.

The microfluidic methodology involves using a solvent to first dissolve the bulk
material/compound, after which an anti-solvent would be added to the dissolved solution
to decrease the drug solubility and ultimately induce substrate precipitation. The benefits
of using nanoprecipitation include high efficiency and low-costs. Nanoprecipitation does
not require high temperatures, ultrasonication, chemical reactions, additional surfactants or
toxic solvents which can affect the chemical structure of the substrate. The characteristics
of the nanoparticle can also be controlled by altering the substrate concentration, solvent
type, ratio of solvents, polymer type and temperature129. One nanoprecipitation method
involves using water as the solvent and acetone as the anti-solvent. The interaction between
acetone and water in contact with the substrate precipitates the substrate polymer. The
precipitate exhibits change in hydrodynamic volume and surface chemistry38. Lamer et al.
proposed that the formation of the nanoparticle occurs through two steps130. First,
nucleation of small aggregates of polymer in a supersaturated solution corresponds to a
reduction in drug solubility by the addition of an anti-solvent. In the second step, the
nanoparticle nuclei grow until the stability of the colloidal particle has been reached.
Stabilizers can also be added to prevent the dissolution of particles and redeposition into
larger particles. The preferential shape of these nanoparticles is spherical because the
polymer chains are homogeneously distributed in the solution during nanoprecipition131,132.

As mentioned before, microfluidics is a variation of nanoprecipitation. The benefits of this
technique variant are that the flow rate and/or ratio of the solvent and anti-solvent can be
controlled. In continuous-flow microfluidics, the solvents are manipulated through
microfabricated channels connected at a junction. There are two types of microchannel
geometry: T-junction and cross-junction or flow focusing channels (Fig. 1.2). The
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interaction between the solvents at the junction promotes the formation of monodispersed
nanoparticles133. Nanoparticles synthesized by this method are more uniform in size and
morphology compared to the batch process38.

Figure 1.2. Droplet formation using different microfluidic junction geometry (a) crossjunction and (b) T-junction.

1.6 Summary and Rationale
Polysaccharides such as pectins and starch-like glucans are key bioactive phytochemicals
in North American ginseng root. It was recently previously reported that the
immunostimulatory properties of North American ginseng are chiefly due to this PS
component. Contemporary studies have also demonstrated that these PS have antioxidant,
immunomodulatory and immuno-protective properties29,59,134. The potency of ginseng PS
was shown to be related to its molecular weight – higher molecular weight PS were more
potent50,97. Evidence indicates that PS elicits an immune response through TLR signalling
via the NF-kb pathway52. Specifically, TLR4 and CD14 have been implicated in the
activation of macrophages by ginseng PS52,99. Although ginseng PS are pharmacologically
active, the effects are limited by its large molecular size which inhibits its absorption in the
gastrointestinal tract. The bioavailability of PS is also limited by its hydrophilic nature.
However, the transport of PS has not been comprehensively studied because of the lack of
chromophores in ginseng PS. Moreover, the limited UV activity of PS poses a challenge
for the quantification of PS.
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Application of nanotechnology to ginseng PS to control and modify molecular size
potentially allows for greater bioavailability. Akhter et al. demonstrated that nanosizing
ginseng PS by nanoprecipitation using microfluidics reduces the particle size of PS while
increasing its crystallinity38. These nanoparticles exhibits marked accumulation in the
dermis, increased cellular uptake and enhanced immunostimulatory activity compared to
its bulk form38. Their results suggest that these observations are likely to be primarily
attributed to the physicochemical changes rather than changes to the chemical structure
following microfluidic processing of the bulk PS38. Various factors may have also
contributed to the observation of enhanced biological effect such as potential selectivity of
PS molecules by the microfluidic procedure, change in PS mechanism of action or
alteration of PS binding kinetics to TLR or CD14. Thus, the basis for the apparent increase
in PS biological effect and the transport of PS and its nanoparticle needs to be elucidated.
This study focuses on the characterization of NPPS physicochemical properties and
investigates if NPPS acts similar to bulk PS. The size and morphology of NPPS and the
influence of PS molecular weight on the nanomorphology are studied. Furthermore, the
penetration of NPPS across a monolayer is investigated using a novel bioassay to
characterize the enhancement of PS transport across a monolayer model. The
immunostimulatory activity and mechanism of activation of NPPS are studied to determine
the effects of nanosizing on the pharmacodynamics of bulk PS.

1.7 Hypothesis and Aims
Hypothesis:
1. Nanosizing ginseng PS using microfluidic processing reduces their particle size and
improves their permeability across the membrane barrier.
2. Nanosizing selectively incorporates higher molecular weight and more bioactive
polysaccharides into nanoparticles rendering higher immunostimulatory activity.
3. NPPS possess different cellular mechanism of action as compared to bulk PS, and this
contributes to their enhanced immunostimulatory activity.
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Aim 1: Synthesize nanoparticles from ginseng PS using microfluidic processing and
characterize physicochemical properties and immunostimulatory activity in vitro.
Nanoparticle synthesis was conducted to ascertain success in replicating the methodology
reported by Akhter et al. and for further refinement. Modification of the methodology was
performed to address the limitations of the aforementioned procedure and determine
parameters which were previously not investigated by Akhter et al. The physicochemical
properties – size and morphology – of the NPPS were examined as part of the modification
and characterization process.

Aim 2: Compare the penetration of bulk PS and NPPS across a membrane barrier to
establish the influence of particle size on its permeability. The transport of NPPS and PS
across cell/membrane barriers was investigated in vitro using a HaCaT keratinocyte
monolayer. Quantification of the passage of bulk PS and NPPS across the monolayer was
performed using a macrophage-stimulation-based biological assay.

Aim 3: To determine whether the molecular weight of bulk PS influences the nanosizing
process and immunostimulatory activity of NPPS. Size and morphology were examined as
potential physicochemical properties influenced by the molecular weight of the substrate –
PS. In vitro stimulation of RAW 264.7 macrophages was used as an experimental model
to study immunostimulatory effect.

Aim 4: To determine whether nanosizing bulk PS changes the mechanism underlying the
immunostimulatory action. In vitro stimulation of RAW 264.7 macrophages was used as
an experimental model. To determine whether TLR-mediated pathway was involved, two
experimental designs were used: LPS-induced desensitized macrophages and use of a
selective TLR2/TLR4 antagonist.
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physicochemical and biological properties of
nanoparticles prepared from American
ginseng polysaccharides
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2.1 Introduction
North American ginseng has been widely reported to be immunomodulatory in vivo with
both immunostimulatory and immunosuppressive effects1–3. They have been used to
manufacture various nutraceuticals – a standardized dietary product – such as COLD-FX®️
and JamiesonTM Canadian Ginseng. The immunostimulatory effects are exerted by the
ginseng polysaccharides (PS), which are derived from the cell wall of the ginseng root4.
Ginseng PS are composed of complex chains of monosaccharides high in galactose (Gal),
arabinose (Ara), galacturonic acid (GalA), rhamnose (Rha) and glucose (Glc)5.
Polysaccharides are heterogeneous in nature due to a high degree of variation in the number
and type of monosaccharide repeating units. As a result, a wide range of diversity is present
in the solubility, hydrophilicity, molecular weight, structure and conformation of PS.
Previous studies have shown that the biological effects of ginseng PS are mainly attributed
to higher molecular weight PS rather than lower molecular weight PS6,7.

Although diverse biological effects of PS have been reported, their effects are limited by
its bioavailability. The large molecular size of PS and their hydrophilicity are both limiting
factors to their absorption in the gastrointestinal tract6,8. These limitations to bioavailability
can be potentially addressed by the application of nanotechnology to PS to modify particle
size/polarity. It has been well-demonstrated that reducing the particle size of large and
poorly permeable compounds to the nano-scale range improves its oral bioavailability9,10.
A nanosizing methodology for ginseng PS has been developed by Prof. Lui and
Charpentier's group to synthesize nanoparticles of ginseng PS (NPPS) by nanoprecipitation
using continuous-flow microfluidics11. The resulting NPPS exhibited uniform and
spherical characteristics with a narrow size distribution (20 ± 4 nm)11. In addition, the
ginseng NPPS were monodispersed (i.e., uniform size and shape) with a higher crystallinity
(i.e., higher order of structure) than the bulk material11.

Similar to nutraceuticals, quality control of ginseng NPPS physicochemical properties is
critical for ensuring safety and efficacy. For regular herbal products, phytochemical (i.e.,
bioactive compounds) profiling is the usual approach. However, to develop high-quality
nanoparticles as nutraceuticals, a set of physicochemical parameters are usually used in the
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evaluation process. In this study, we evaluated size and morphology, and measured the
penetrative ability of the nanoparticles.

Previously, Akhter et al. used fluorescent-labelled NPPS to study its disposition in skin
after topical application to hairless mice. It has been shown that following treatment, NPPS
passed into the dermis mainly through the transappendageal route (hair follicle, sweat
gland) and dispersed throughout the dermis12. Furthermore, NPPS accumulated in dermal
blood vessels and exhibited greater immunostimulatory activity than PS in samples
collected from the skin12. Ginseng NPPS also demonstrated greater immunostimulatory
activity in vitro compared to bulk PS11. In particular, ginseng NPPS increased tumor
necrosis factor alpha (TNFα), interleukin (IL)-6, IL-1β and nitric oxide (NO) production
in RAW 264.7 macrophages11. The authors concluded that the enhancement of biological
activity of NPPS in macrophages might be related to its greater cellular uptake. NPPS
accumulated within macrophages whereas bulk PS accumulated apically of the plasma
membrane12. This apparent increase in cellular uptake of NPPS was speculated to be
secondary to changes in surface chemistry and size rather than skeletal structure11.

The increase in biological membrane permeability of NPPS is expected to enhance
absorption from gastrointestinal tract and increase systemic bioavailability. This should
also apply to the penetration of dermal barrier after topical application. The uptake of the
nanoparticle depends on its physicochemical properties such as size or charge.
Nanomaterials can be transported across the skin through transappendageal (diffusion via
follicles/glands), paracellular and/or transcellular transport. Generally, nanoparticles that
are transported transcellularly via receptor mediated-endocytosis or non-specific
mechanisms13,14. The fate of the nanoparticle within a cell also varies depending on the
compound, cell type and nanoparticle type14. Following endocytosis, the nanoparticles can
be incorporated into endosomes, which could then be excreted or participate in the fusion
with late endosomes that subsequently fuses with lysosomes14. The nanoparticles could
also distribute in the cytoplasm or localize in the nucleus, mitochondria, ER or Golgi
apparatus14. The lack of understanding on the fate of nanomaterials poses a potential issue
of toxicity.
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The amount of NPPS penetration was not measured by Akhter et al. due to difficulties
quantifying the concentration of PS and its nanoparticle. Furthermore, there is a lack of
technology for quantitation of PS polymers which do not have chromophoric moieties3. To
address this, a biological assay was developed to estimate the amount of PS in biological
samples. However, this assay is only viable under in vitro conditions in the absence of
biological influences which could affect the specificity of the assay.

In this study, penetration of NPPS and its bulk substrate (PS) across a cell monolayer was
evaluated in order to provide a biological basis to explain the observed difference in
deposition profiles between NPPS and bulk PS in dermal tissue in vivo following topical
adminisration12. In order to verify the observed enhanced dermal penetration of NPPS in
vivo, human keratinocytes (HaCaT) were used as an in vitro biological barrier to bulk PS
and NPPS. The in vitro keratinocyte monolayer model – herein referred to as a monolayer
model – was used to determine if NPPS penetrate the dermal barrier better than ginseng
PS. The monolayer model is made up of a monolayer of confluent keratinocytes cultured
on a trans-well insert with an established membrane integrity. The monolayer model was
used to enable the examination of the penetration of a biological membrane in isolation
without other biological influences.

Since ginseng PS are known to be heterogeneous in size distribution, it is not certain how
this factor influences the nanosizing process. To address this question, bulk PS was
separated by ultrafiltration through different membranes of defined pore sizes into subfractions of different molecular sizes. The PS sub-fractions were used as substrates for the
preparation of NPPS, which was subsequently subjected to physicochemical and biological
characterization in vitro. In summary, this chapter will address the modification of the
microfluidic procedure, physicochemical and biological characterization of NPPS. We
hypothesized that microfluidic processing of PS reduces particle size, improves
permeability with heightened biological activity and that molecular size of PS is a
determinant of resulting NPPS. In addition, we were able to develop an in vitro
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keratinocyte monolayer model that was coupled with a bioassay for PS quantitation to
evaluate the transport of NPPS.

2.2 Experimental Procedure
2.2.1 Materials
Four-year-old Panax quinquefolius roots were collected in 2007 from five separate farms
(Ontario, Canada) to prepare aqueous extracts which were then combined to produce a
composite extract. The composite extract was provided by the Ontario Ginseng Innovation
and Research Consortium for further extraction and isolation of ginseng PS.

HaCaT human keratinocytes (CLS 300493) purchased from Cell Lines Services GmbH
(CLS; Germany) were used to prepare an in vitro monolayer model and RAW 264.7 murine
macrophages (ATCC TIB 67) provided by Dr. Jeff Dixon (Department of Physiology and
Pharmacology, University of Western Ontario, Canada) were used for pharmacological
studies. Dulbecco’s Modified Eagle’s Medium (DMEM) and Fetal Bovine Serum (FBS)
(US origin) were purchased from Gibco Laboratories (USA). Lipopolysaccharides (LPS)
from Escherichia coli (O111:B4) and Griess’ reagent (modified) were purchased from
Sigma-Aldrich (Canada).

2.2.2 Preparation of ginseng PS
2.2.2.1 Crude PS ginseng.
Dried ginseng root was grounded and soaked in nano-pure water (1:20) at 40 °C for 4 hrs.
The extraction procedure was repeated three times and the extracts were combined,
centrifuged and filtered to remove any particulate matters. The extract was concentrated
via rotary evaporator (Buchi) under vacuum at 50 °C and lyophilized using a freeze dryer
(Labconco). Ginseng PS fraction was precipitated by the addition of 95% ethanol in four
sequential volumes, giving a final concentration of ethanol of 40% ethanol (v/v). The
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solution was centrifuged at 350 x g for 10 mins to obtain the precipitate (pellet). The pellet
was further purified by dissolving the pellet in nano-pure water at approximately 1 g/mL
and precipitated again with ethanol to remove remaining water-insoluble materials. The
precipitate was lyophilized with a freeze dryer to obtain the crude PS ginseng extract. The
crude PS extract was further processed by deproteinization using prepared Sevag reagent
made with n-butanol and chloroform (1:4 ratio by volume). Briefly, powdered crude PS
(10 g) was dissolved in nano-pure water (300 mL) and partitioned five times with 1000 mL
of Sevag reagent. Once again, PS was precipitated from the solution by 95% ethanol and
lyophilized via freeze dryer to obtain the bulk PS extract.

2.2.2.2 Sub-fractionation of bulk ginseng PS by ultrafiltration.
Ginseng PS were separated into molecular weight sub-fractions through ultrafiltration
using Amicon® Ultra centrifugal filter devices (Millipore Sigma) (Fig. 2.1). Five
Amicon® Ultra tubes with different pore sizes for a specified nominal molecular weight
limit (NMWL) were used: 100,000, 50,000, 30,000, 10,000 and 3,000. Herein, NWML
will be referred to in kilodaltons (e.g., 100 kDa) and Amicon® Ultra tubes as UF tubes.
Briefly, PS were dissolved at a concentration of 1 mg/mL and sonicated for 1 hr. Five
millilitres of the PS solution were placed into the 100 kDa UF tube and centrifuged at 4000
x g in a swinging bucket rotor at 25°C for 30 mins. Subsequently, the precipitate was
removed and labelled as the ≥ 100 kDa fraction while the filtrate was diluted to a final
volume of 5 mL and transferred into the 50 kDa UF tube. The precipitate after
centrifugation was labelled as the 50-100 kDa fraction. Once again, the filtrate was diluted
to 5 mL and transferred into the 30 kDa UF tube. The precipitate was labelled as the 30-50
kDa fraction. This was performed for a total of 10 times.

After ultracentrifugation, the precipitates were combined and concentrated to 10 mL and
transferred into a 15 mL centrifuge tube. Samples were frozen overnight and then
lyophilized for 3-4 days to obtain ≥ 100 kDa, 50 - 100 kDa and 30 – 50 kDa PS. Herein,
the fractions will be referred to as large (L-PS), medium(M-PS), small (S-PS), respectively.
Samples were then weighed, and the final yield was calculated.
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Figure 2.1. Schematic illustration of ultrafiltration procedure for separation of ginseng
polysaccharides by nominal molecular weight limit (NWML).

2.2.2.3 Synthesis of ginseng PS nanoparticles by microfluidic nanoprecipitation.
NPPS and sub-fractionated NPPS were prepared from bulk PS and sub-fractionated PS
respectively by a continuous microfluidic system using T-junction geometry (Fig. 2.2).
Stainless steel T-junction or Micro-TEE (Upchurch Scientific) was used, with an inner
diameter of 1500 µM. The microfluidic setup consisted of two infusion syringe pumps,
Legato 1100 and Legato 2200 (KD Scientific) attached to the arms of the T-junction. The
first pump attached to Arm 1 was used to infuse the solvent which was an aqueous solution
of deproteinated ginseng PS. This PS solution was prepared using nano-pure water at a
concentration of 0.55 g/mL followed by ultrasonication. The second pump attached to Arm
2 was used to pump the anti-solvent (acetone; 100%; HPLC grade). The solvent and antisolvent were infused at a ratio of 1:20. Specifically, the solvent was infused at 0.01 mL/min
and the anti-solvent at 0.2 mL/min. Attached to Arm 3 is PEEK tubing with an outer
diameter of 1500 µM and an inner diameter of 75 µM (Upchurch Scientific). Arm 3 was
directed towards a reservoir containing 15 mL of acetone, which is continuously mixed
with a magnetic stirrer at room temperature to prevent sedimentation. The dispersion
containing synthesized NPPS was collected from the reservoir and concentrated to remove
excess acetone and centrifuged at 350 x g for 15 mins to sediment the precipitate. The
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precipitate was recovered by removing the supernatant by vacuum suction. The precipitate
was resuspended and then combined into a composite batch. The batch was concentrated
and centrifuged again prior to lyophilization by freeze drying. The lyophilized powdered
ginseng NPPS was stored at 4 °C before ready for experimentation.

Water-acetone system

Aq. solution of ginseng
PS (0.55 mg/mL)
@ 0.01 mL/min

Acetone @
0.2 mL/min

Figure 2.2. Experimental setup of continuous microfluidics system for the preparation of
ginseng polysaccharide nanoparticles. Pump 1: Solvent phase (H2O) containing ginseng
polysaccharide. Pump 2: Anti-solvent (acetone). Adapted from Akhter et al.12.

2.2.3 Physicochemical characterization of ginseng PS nanoparticles
The size and morphology of nanomaterial samples were examined using transmission
electron microscopy (TEM) (Philips CM10). No stain was used for the samples.
Nanoparticles for TEM imaging were prepared by dispersing samples in acetone. The
dispersion products were deposited onto formvar-coated copper grids. TEM images were
also measured by ‘ImageJ’ software to assess the size distribution of the sample. The
contrast of TEM images was adjusted to assist visualization and measurement of particles.

The size distribution of the nanomaterials was measured by dynamic light scattering (DLS)
(Malvern Zetasizer Nano ZS(R)) instrument; Nano S model ZEN 1600, Malvern, Orsay,
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France). Briefly, the PS samples were dispersed in water and then ultrasonicated for 5 mins
to assist in the dispersion. Dispersed samples were loaded into a disposable polystyrene
sizing cuvette (DSTS0012) and backscattering measurements (173°) was collected at room
temperature (25°C) at a measurement position of 4.65 mm. The sizing cuvette containing
the sample was allowed to equilibrate for 30 sec before 3 consecutive acquisitions that were
averaged over 2 sec were recorded.
2.2.4 Biological analyses
2.2.4.1 Cell culture.
Spontaneously transformed aneuploid immortal human keratinocytes (HaCaT) and
Abelson murine leukemia virus transformed macrophages (RAW 264.7) were cultured in
DMEM supplemented with 10% FBS and 1% penicillin/streptomycin. Cell cultures were
maintained at 37℃ in a humidified incubator with 10% CO2. The concentration of CO2
was used in accordance with the concentration of sodium bicarbonate (3.7 g/L) contained
in the media to maintain a physiological pH of ~ 7-7.4. HaCaT cells were passaged every
8-10 days at approximately 80% confluency. Cell culture media were changed biweekly.
RAW 264.7 cells were passaged every 3-4 days at approximately 80% confluency. Cell
culture media was changed one day prior to passage. Cell viability was determined by
trypan blue dye exclusion test, which is based on the permeability of non-viable cells to
the dye. Cell cultures were tested for mycoplasma contamination using the MycoAlert®
Mycoplasma Detection Kit (Lonza). None of the cell cultures used were tested positive.

2.2.4.2 Stimulation of macrophage function in vitro.
Immunostimulatory activity of PS and NPPS was investigated using RAW 264.7 murine
macrophage cells. Macrophage cells were seeded during the logarithmic phase (~80%
confluency) into 96-well tissue culture plates at a density of 1.5 x 105 cells per well and
incubated at 37 ℃ and 10% CO2. RAW 264.7 cells were treated with PS and NPPS for 24
hrs. Treatment concentrations of PS and NPPS were at 50, 100, 200 and 300 µg/mL. At 24
hrs the cell culture supernatant was removed to measure NO production by the
macrophages. Data was subsequently used to construct bioassay standard curves for PS
and NPPS.
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To study the effects of substrate molecular weight on the immunostimulatory effects of
sub-fractionated NPPS samples (i.e., L-NPPS, M-NPPS, S-NPPS), RAW 264.7
macrophages were treated with 0 – 200 µg/mL of sub-fractionated NPPS. In addition, cells
were treated with 0 – 200 µg/mL of sub-fractionated ginseng PS (i.e., L-PS, M-PS, S-PS)
and compared with ginseng NPPS to investigate the effects of nanosizing on its
immunostimulatory activity. At 24 hrs the cell culture supernatant was removed to measure
NO production by the macrophages.

2.2.4.3 In vitro model for measurement of penetration of PS and NPPS across
monolayer.
The purpose of this model was to measure the penetration of ginseng PS and NPPS across
a viable cellular membrane with biological integrity, which may provide an estimation of
bioavailability. A keratinocyte monolayer was used to simulate a dermal barrier. The in
vitro skin model consists of keratinocytes cultured on polyethylene terephthalate (PET)
trans-well inserts (1 µM pore) placed within a 24-well plate (Fig. 2.3). HaCaT cells were
seeded at a density of 5.0 x 104 cells/ insert. Inserts were immersed in cell culture media
and incubated until confluency. Cell culture media in the apical and basolateral
compartment were changed biweekly. Three days post-confluency, transepithelial
electrical resistance (TEER) of the keratinocyte monolayer was measured with EVOM2
STX2 electrodes and monitored to ensure membrane integrity. Monolayers with a TEER
less than 50 Ω*cm2 attributed to low membrane integrity were discarded. The threshold
was determined based on the study conducted by Ferreira et al., and data from preliminary
studies (i.e., TEER values at non-confluence)15.
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Trans-well insert
Well
Media

Figure 2.3. Schematic of penetration model. HaCaT keratinocyte monolayers were
cultured on 1 µM transwell inserts (polyethylene terephthalate). Transwell inserts were
immersed in cell culture media inside wells of a 24-well plate.

Both the apical and basolateral compartments were filled with 1000 µL of culture media.
Experiment to evaluate sample penetration over time across the keratinocyte monolayer
into the basolateral compartment was performed by replacing the media in the apical
compartment with 1000 µL of ginseng NPPS or PS (300 µg/ mL). 1000 µL of conditioned
media was removed from the basolateral compartment at 6, 12 and 18 hrs for quantitation
of PS and NPPS. At each time point of sampling, an equal volume of fresh media was
added for replacement. Herein, samples obtained from the basolateral compartment will be
referred to as conditioned media.

To evaluate the influence of concentration on the penetration of samples across the
keratinocyte monolayer, the apical compartment was treated with media (1000 µL)
containing 0, 50, 100, 200 or 300 µg/mL of ginseng NPPS or PS for 24 hrs. Thereafter,
conditioned media were removed from the basolateral compartment and stored until
quantification via bioassay.
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2.2.4.4 Bioassay for quantitation of PS and NPPS
In the absence of a chemically-based methodology to quantify PS and NPPS, a bioassay
that was based on the stimulation of NO production by RAW 264.7 macrophage was
developed to quantify the presence of PS and NPPS in the basolateral compartment
(Appendix A1). A standard curve based on stimulation of plated macrophages NO
production 24 hrs following treatment with 0, 50, 100, 200 and 300 µg/mL of ginseng PS
or NPPS was prepared. Nitric oxide was estimated indirectly by measuring nitrite
concentration by the Griess’ assay. The standard curve was constructed as a semi-log plot
from nitrite concentration (dependant) and treatment concentration (independent) (Fig.
A.1). The standard curve was subsequently used to calculate the unknown sample
concentrations.

To determine the concentration of PS or NPPS found in the conditioned media collected
from the bio-membrane penetration study, experimental samples (200 µL) were added to
the macrophage cultured in 96-well plates. The accumulation of NO in the culture media
over 24 hrs was determined by the Griess’ reagent test. The concentration of PS or NPPS
in the samples was estimated from the PS or NPPS standard curve, respectively.

2.2.4.5 Quantification of NO production
Nitric oxide production was measured by colorimetric detection of the presence of nitrite
ion in the media. Nitrite is a final product of the NO oxidation pathway. Nitric oxide in
culture supernatants was determined using modified Griess’ reagent containing 0.5%
sulfanilic acid, 0.002% N-1-naphthyl-ethylenediamine dihydrochloride and 14% glacial
acetic acid (Sigma-Aldrich, USA). Briefly, 50 µL of Griess reagent was added to 50 µL of
culture supernatant and incubated away from light at room temperature for 15 mins.
Absorbance at 540 nm wavelength was measured using uQuant microplate reader (Biotek
Inc.). Wells containing air bubbles which distort measurements were excluded. Nitrite
concentrations in samples were estimated from the standard curve prepared by dilutions of
sodium nitrite.
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2.2.5 Statistical analysis
Data are presented as mean ± standard error of the mean (SEM). The two-way analysis of
variance (ANOVA) followed by Bonferroni’s post hoc test was used for the comparison of
means between treatment groups. The one-way analysis of variance (ANOVA) followed
by Dunnett’s post-hoc was used for the comparison of means with the untreated control
(vehicle). Statistical analysis was performed using GraphPad Prism 6 software (San Diego,
CA). Values P < 0.05 compared between treatment groups were considered statistically
significant.

2.3 Results and discussion
In this study, crude ginseng PS was isolated from a water extract of 4-year-old Ontariogrown American ginseng roots by precipitation with 40% ethanol with a yield of ~ 9 ± 1
% by dry-weight of root sample. This is consistent with what was reported in other studies6.
Ginseng NPPS were prepared from bulk PS based on the microfluidic methodology
designed by Akhter et al.11 (see Fig. 2.1.). This procedure was modified successfully (i.e.,
substrate concentration) to address susceptibility for sample build-up in the T-junction and
PEEK tubing. Nanosizing ginseng PS from 15 batches provided a yield of ~ 95% by weight
relative to the substrate (i.e., bulk PS) weight. Subsequently, the resulting nanoparticles
were characterized physicochemically and compared with the ginseng NPPS
characteristics reported by Akhter et al.11. Penetration of ginseng NPPS across the dermal
barrier was investigated to provide a biological basis for the apparent increase in deposition
of ginseng PS into the dermis in vivo12. The influence of PS characteristics – namely its
molecular weight – on the characteristics of the nanoparticles and its potency were also
studied. The results of these studies were presented below.
2.3.1 Morphology and size distribution of ginseng PS and NPPS
Transmission electron microscopy (TEM) was performed on a NPPS composite sample
prepared from 15 batches and a comparable bulk PS sample was used as a reference. As
shown in Fig. 2.1a, bulk PS has an indistinct and unresolved structure with no regular
nanomorphology. The unclear TEM micrograph is expected as one of the challenges
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associated with the characterization of PS structures is that they have poor electron density,
making it difficult to obtain high-resolution TEM images16. Furthermore, no stains were
used during TEM preparation of PS samples. PS macromolecules and supramolecules
(higher-leveled structures of macromolecules) are present as indicated within the
micrographs by the arrows. Furthermore, agglomerates of PS were observed in the TEM
micrograph. The TEM micrograph indicates that the PS supramolecules were amorphous
and irregular in shape. Preliminary studies (data not shown) investigating the effect of
aggregation has shown that the bulk PS would aggregate at concentrations past the
solubility threshold (i.e., ~ 0.75 mg/mL) and rapidly sediment. The TEM micrograph of
the nanosized ginseng PS (Fig 2.4b) showed that the prepared nanoparticles were much
more uniform and within the nano-size range (< 100 nm). Particle size analysis of the TEM
micrograph using “ImageJ” software of Fig. 2.4b gave a molecular distribution of
approximately 12 – 26 nm in diameter with an average size of 19 nm (Fig. 2.5). The
nanoparticles were also distinctly separated from one another and did not agglomerate.
From these images, it is apparent that the morphology of ginseng NPPS was much more
regular in size compared to PS, with spherical and smooth surfaces. The nanomorphology
of these ginseng NPPS was similar to the characteristics of the ginseng NPPS reported by
Akhter et al. Briefly, the authors also reported monodispersed nanoparticles that were
unimodal and spherical in shape. These nanoparticles synthesized by Akhter et al. were
characterized to be on average 20 ± 4 nm in diameter11.
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Figure 2.4. Transmission electron microscopy (TEM) micrograph of (a) bulk PS and (b)
NPPS. Ginseng NPPS were synthesized by nanoprecipitation using microfluidics with a
1:20 flow rate ratio and 75 µm (inner diameter) PEEK tubing. Samples were dispersed in
acetone and TEM was performed using Philips CM10 without using any stains. Arrow 1:
PS macromolecule. Arrow 2: PS supramolecules. Arrow 3: PS agglomerates. Arrow 4:
NPPS.
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Figure 2.5. Size distribution of ginseng NPPS prepared by nanoprecipitation using
microfluidics. Particle size is in diameter and was measured by ImageJ Software. Data
presented was from a representative experiment.

In addition to TEM, the size distribution of the prepared NPPS was characterized using
dynamic light scattering (DLS). As a comparison, bulk PS was also analyzed via DLS.
Two separate size distributions were observed with bulk PS at approximately 90 – 140 nm
and 820 – 1800 nm in diameter, with a mean peak of 110 nm and 1200 nm, respectively
(Fig. 2.6a). The small and large size components had an area under the curve (AUC) of
14% and 86%, respectively. In contrast, NPPS had a single mean particle size of ~34 nm
in diameter was measured (Fig. 2.6b). The measured particle size range of 28 – 44 nm
corroborates with the TEM results. Results from the DLS indicate the hydrodynamic
diameter of these particles in water based on a large number of molecules using light
scattering. In comparison, TEM measurements from ImageJ (Fig. 2.5) use only a small
number of measurements (i.e., ~ 100). Both results (Fig. 2.5 and Fig. 2.6) indicate
successful nanoparticle formation (i.e., < 100 nm in diameter). TEM samples are dispersed
and subsequently dried on a copper grid whereas DLS samples are dissolved in a solvent.
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With this consideration, the difference in size distributions indicates NPPS interact to a
small degree non-covalently when in solution.

µ = 1199.0 nm
µ = 107.4 nm
σ = 165.8 nm
σ = 11.3 nm

Size (d.nm)
µ = 34.0 nm

σ = 2.2 nm

Size (d.nm)

Figure 2.6. Dynamic Light Scattering of (a) ginseng PS and (b) NPPS using Zetasizer
Nanosizer. Size distribution is presented as the diameter of the particles in nm and
displayed as a function of intensity. Analysis was performed three times. Data presented
was from a representative experiment. µ = mean; σ = standard deviation.

The parameters used for microfluidic processing of ginseng PS in the study conducted by
Akhter et al. was similar to the parameters used in this current study, namely the antisolvent to solvent ratio, flow rate, MicroTEE thru-hole, and PEEK tubing size. The main
difference between these two procedures was the concentration of substrate used (0.55
mg/mL) and the technique to recover the product. The concentration of the substrate was
not reported in the reference procedure. The concentration of the substrate used in the
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procedure was also modified to allow for higher success rates (i.e., no clogging/ system
errors) and greater yields. Based on the results (Fig 2.5), these alterations to the
microfluidic procedure did not seem to greatly affect the average size (± 1 nm) or
morphology of the nanoparticle compared to those reported by Akhter et al. Thus, the
ginseng NPPS (15 batches) synthesized for our study demonstrated reproducibility (i.e.
size and morphology) of the aforementioned nanoparticles in the study conducted by
Akhter et al.11.

Nanoprecipitation of bulk PS was demonstrated by Akhter et al. to not affect its chemical
structure but increases its crystallinity11. Although there is higher structural order, the
NPPS are still amorphous. Furthermore, the nanoparticles were formed due to interactions
between the solvent and anti-solvent at the channel junction rather than through reactions
with the acetone17,18. The chemical structure of a substrate is not typically altered following
nanoprecipitation unless compounds, markers or tags are conjugated to the substrate and if
the substrate reacts with the solvents. In a study conducted using nanoparticles prepared by
bottom-up nanocrystallization (i.e., probe-sonication controlled precipitation), the
chemical structure of the substrate compound did not change following size reduction19.
This was attributed to changes in the crystalline structure and no functional changes were
observed19. In another study, Zhou et al. reported that hydroxycamptothecin (HCPT:
C20H16N2O5) nanorods and nanoparticles prepared by nanoprecipitation did not exhibit
differences in its chemical structure compared to bulk HCPT20. These functionality
changes could be attributed to physicochemical changes.

2.3.2 Biological characterization of NPPS
2.3.2.1 Stimulation of macrophage function.
To investigate the pharmacodynamics of the ginseng NPPS with reference to bulk PS, 24hr response in cultured murine macrophages was examined. Ginseng PS and NPPS
treatment showed dose-dependent stimulation of NO production up to 200 µg/ml and no
further increase was observed with a higher dose (Fig. 2.7). The stimulatory response was
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significantly higher with NPPS treatment by approximately 35% at all concentrations. It
should be noted that the maximum response to NPPS was similar in magnitude to that
induced by the positive control (1 µg/ml LPS) (data not shown). Based on the doseresponse data, the respective EC50 values of 73.84 μg/mL and 93.12 μg/mL for NPPS and
PS have been estimated. This provides further evidence of elevated potency with NPPS.

Figure 2.7. Immunostimulatory effects of ginseng PS and NPPS on macrophage NO
production. Macrophages were treated with 0-300 µg/mL of NPPS and PS for 24 hrs. Three
independent experiments were performed in triplicates. Data are presented as mean ± SEM.
Datasets were statistically analysed by two-way ANOVA followed by Bonferroni’s post
hoc test. * Values P < 0.05 compared to the control were statistically significant. # Values
< 0.05 compared between treatment groups were statistically significant.

Nitric oxide as an inflammatory mediator has been widely reported to be involved in the
immunomodulatory activity of plant PS21–23. The up-regulation of NO production observed
with ginseng PS treatment was consistent with the results reported previously in the
literature4,24. The increase in NO production by NPPS was also consistent with the study
conducted by Akhter et al.11. Both studies show that NPPS are more effective
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immunostimulating agents compared to ginseng PS. The authors also reported enhanced
TNFα, IL-1β and IL-6 production induced by NPPS11. This suggests that the apparent
enhancement is not limited to stimulation of NO production but possibly related to the NFκB pathway12. Perez et al. recently synthesized another type of ginseng nanoparticle and
studied their pharmacological effects25. In this case, gold/silver salts and whole ginseng
berry extract (GBE) instead of pure PS were used. The main phytochemicals present in
ginseng berry extract are PS, phenolics, flavonoids, tannins, and ginsenosides.
Characterization of the resulting nanoparticles suggested that ginsenosides, acidic
polysaccharides, polyphenols and reducing sugars were capped onto the gold or silver
nanoparticles25. These gold or silver core GBE nanoparticles were non-toxic and had
enhanced pharmacological effects (e.g. free radical scavenging activity) compared to bulk
GBE25. Although the nanoparticles from both studies are different, both indicated enhanced
bioactivity following reduction of hydrodynamic volume25.

Various other nanoparticles have similarly demonstrated enhanced biological effects
compared to its corresponding substrate, which includes enhanced immunological,
bactericidal or toxic effects. Morones et al. reported that the bactericidal effects of silver
nanoparticles were improved with decreasing size due to the increased surface area
interaction26. In a different study, zinc oxide (ZnO) nanoparticles exhibited enhanced
antimicrobial effects compared to bulk ZnO27. Padmavathy et al. also reported that the
enhancement of effect was inversely related to its size27. Although in each case different
methodology and materials were used, the enhancement was consistently attributed to the
change in size and surface chemistry because of the absence of functional changes to the
molecules.

2.3.2.2 Penetration of NPPS across keratinocyte monolayer model in vitro.
2.3.2.2.1 Validation of the monolayer system.
Monolayer models have been regularly used in the pharmaceutical industry and in
academic research institutions to estimate and predict intestinal drug absorption in vitro
and study the mechanisms underlying drug transport. These models are often used to
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identify relevant drug transporters, potential drug absorption complications, and if the drug
is actively or passively transported. In these models, cell monolayers (e.g., Caco-2 or HT29
intestinal epithelial cells) are cultured on permeable inserts to simulate a cellular
barrier28,29. Various models have also been developed to study drug transport across other
barriers, such as the blood-brain barrier or dermal barrier. Examples of these models
include human cerebral microvascular endothelial cells (hCMEC/D3) or immortalized
human keratinocytes (HaCaT), respectively30,31. In this current study, we used a HaCaT
monolayer model to study the transport of ginseng PS and NPPS across cultured
keratinocyte monolayer. Transepithelial Electrical Resistance (TEER) was used to
ascertain the functional integrity of monolayers in this study30. Typically, higher resistance
is measured when the monolayer has high membrane integrity (i.e., tight junctions) due to
the interference of the monolayer between electrical probes. A lower TEER threshold (>
50 Ohms*cm2) was used to select intact keratinocyte monolayers. The lower threshold
represents the baseline TEER to determine membrane integrity. Moreover, as shown in
the data presented below, bulk PS, which are known to have limited systemic
bioavailability also showed limited, if any, penetration. This provides further evidence of
a functional monolayer system.

To determine the penetration of a test compound across a monolayer, the change in its
concentration in the compartment(s) as a function of time has to be measured. The
quantification of a test compound is typically performed using chemical detection
technology. However, quantification of plant PS is difficult because of its lack of
chromophoric moieties. There is also a lack of effective chromatographic techniques to
provide resolution to ginseng PS which are known to be heterogeneous in molecular size.
Akhter et al. has developed a methodology to label PS with a fluorescent tag (5-FTSC) for
bioimaging but has many limitations for quantitative analysis12. A bioassay was used in
this study to measure PS concentration (Fig. A.1). This bioassay was developed based on
the initial characterization study of the immunostimulation of macrophages by ginseng PS
and NPPS as described earlier (Fig. 2.7). A standard curve was prepared by measuring 24hrs NO production by RAW 264.7 macrophages with 50 – 300 μg/mL concentrations of
ginseng PS and NPPS (Fig. A.1). The PS and NPPS standard curves are sensitive to sample
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concentrations between the stimulation conditions (50 – 300 μg/mL). Although the
bioassay can estimate sample concentration based on its degree of macrophage stimulation,
other stimulatory factors may be present in the sample which may have been released by
the keratinocytes that could interact with the sample. If that is the case, there may be an
overestimation of the result, affecting the specificity of the assay. Despite the limitations,
this monolayer model has allowed us to compare the penetrations of PS and NPPS and test
our hypothesis. In view of our failure to monitor changes in membrane integrity at the end
of the penetration experiment, we could not rule out the induction of monolayer toxicity
(dysfunction) rendering a false-positive-evidence for penetration.

2.3.2.2.2 Penetration of ginseng PS and NPPS across monolayer.
To determine whether the keratinocyte monolayer is a barrier to PS and NPPS, a solution
of PS or NPPS (300 μg/mL) was added to the apical compartment and their accumulation
in the basolateral compartment over the course of 18 hrs was determined by a bioassay. As
shown in Fig 2.8, no PS was detectable in the basolateral compartment over the 18-hr
period (PS detection limit: 50 μg/mL). In contrast, significant levels of NPPS were detected
at the 18-hr sampling time-point but not at earlier time-points. This apparent abrupt
increase in penetration may be attributed to the low degree of sensitivity of detection. The
sensitive concentration for NPPS was 50 μg/ml; as compared to ~ 110 μg/ml recorded for
NPPS at 18 hrs. The accumulation at 12 hrs may have been near but below the minimum
sensitive concentration. If so, the increase observed would be comparably small but still
significant. Despite the low sensitivity, results show that it is likely that the keratinocyte
monolayer was a barrier for PS, but not NPPS. The marked increase in penetration at 18
hrs and lack of prior detectable penetration could potentially be attributed to a loss of
membrane integrity over time induced by NPPS. Moreover, the loss of membrane integrity
would have been small enough to maintain the barrier function to PS.
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Basolateral Accumulation (µg/mL)
Figure 2.8. Accumulation of ginseng PS and NPPS in the basolateral compartment over
periodic 6-hr intervals. RAW 264.7 cells were treated with conditioned media (300 µg/mL
PS or NPPS treatment) collected from the basolateral compartment at 6, 12 and 18 hrs for
PS or NPPS quantitation. Concentration was estimated from 24-hr macrophage NO
production using respective standard curves. The sensitivity of bioassay was 50 - 300
µg/mL; therefore, concentrations below 50 µg/mL were undetectable. Experiments were
performed in triplicates and the data are presented as mean ± SEM, n =3. * indicated timedependent differences in accumulation; P < 0.05; two-way ANOVA).

In view of the observed accumulation of NPPS (300 µg/mL) over time across the
keratinocyte monolayer, an additional experiment was conducted to determine whether the
penetration was dependent on the concentration. This may provide additional information
regarding the nature and mechanism of penetration. Four concentrations of ginseng PS and
NPPS were used (50, 100, 200, 300 μg/mL) and the result was expressed based on the
resulting basolateral concentrations (Fig. 2.9).
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As shown in Fig. 2.5, the 24-hr accumulation of PS was insignificant even at the highest
concentration tested (values being below the detection limit of 50 μg/mL). Significant
accumulation of NPPS was detected at treatment concentrations of 200 and 300 μg/mL,
but not at lower concentrations (Fig. 2.9). It was estimated that at 200 μg/mL of NPPS,
approximately 65% of the NPPS load penetrated the monolayer into the basolateral
compartment over the 24-hr period. However, the accumulation was not dose-dependent
between 200 and 300 μg/mL. This may suggest that the penetration of NPPS across the
monolayer was reaching saturation at higher concentrations.

Figure 2.9. Basolateral concentration of PS and NPPS after 24-hr treatment. Conditioned
sample was obtained from the basolateral compartment after 24-hr treatment to the
keratinocyte monolayer model. The model was treated with 0-300 μg/mL of NPPS or PS.
Three independent experiments were performed in triplicates and the data were presented
as mean ± SEM. Datasets were statistically analysed by two-way ANOVA followed by
Bonferroni’s post hoc test. * Values P < 0.05 compared with zero control were statistically
significant.
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The observed enhancement of ginseng NPPS penetration of the keratinocyte monolayer is
consistent with our previous in vivo observation following topical application in hairless
mice (Akhter et al.)12. Furthermore, results are consistent with the poor permeability of
other plant PS that has been reported8. The apparently limited penetration of PS is likely
due to the lack of passive transport pathways which are mainly restricted by its large
particle size. Typically, large particles or agglomerates are engulfed by phagocytosis (> 0.5
μm) leading to downstream lysosomal degradation32. In addition, PS may also undergo
receptor-mediated endocytosis, pinocytosis and macropinocytosis32. These pathways target
particles to early endosomes and may result in downstream basolateral transcytosis or
degradation14. If the metabolites of these degradative pathways are not immunologically
active, the bioassay would not quantify PS that undergo transport by these mechanism(s),
which leads to an underestimation of PS penetration.

We have not studied the basis for the apparent high penetration of NPPS across
keratinocyte monolayer. However, NPPS may undergo several modes of transport across
membrane/cellular structure: (1) passive diffusion; (2) paracellular transport - nano-scale
molecules penetrate basolaterally across the keratinocyte monolayer in between cells due
to their extremely small size (< 50 nm); and (3) transcellular pathway (active transport) endocytotic uptake by keratinocytes followed by basolateral release. This may include
pinocytosis (non-adsorptive or adsorptive), macropinocytosis and/or receptor-mediatedendocytosis. (< 0.5 µM)14,32. It is likely that more than one of these processes may have
occurred concurrently. The relative contributions of these mechanisms may depend on
several factors, including nanoparticle size, lipophilicity and concentration. The last factor
is dynamic and is expected to change with exposure time. Agglomeration of NPPS in
solution can also affect the transport of the nanoparticle.

Our physicochemical analysis showed a reduction in particle size of PS corresponding to a
reduction in hydrodynamic volume (Fig 2.5 & 2.6), which is consistent with what is
reported in the literature11. The reduction of particle size should enable passive transport
of PS particles across the monolayer which is limited by the surface charge and size of the
particles. In a recent publication, nano-formulations of beta-carotene exhibited greater
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kinetic saturation solubility and dissolution compared to bulk beta-carotene33. The nanoformulation was also demonstrated to be taken up by HaCaT keratinocytes faster than the
poorly-soluble bulk-formulations33. In addition, the resorption of the nano-formulations of
beta-carotene decreased with increasing crystalline size of beta-carotene33. In cases like
ginseng NPPS where the nanoparticles consist of the drug itself (i.e., substrate only),
smaller particle size was the main factor which increased bioavailability34,35. Megace ®️ ES
(Par) and TriCor®️ (Abbot) are recent nano-pharmaceutical examples of such nanoparticle
drugs which exhibited enhanced bioavailability34,35. Although different nanomaterials have
different characteristics, the size was a common factor which has been shown to increase
penetration across barriers36. The decrease in particle size of bulk PS following
nanosization also increases surface-area-to-volume ratio37. A larger surface-area-tovolume ratio exhibits greater solubility, faster dissolution, and allows for greater interaction
with the cellular membrane38–40. Therefore, passive transports are more likely.

It is evident that the particle size of NPPS also plays a role in active transport. Li et al.
showed that the transport of lipid nanoparticles across Caco-2 monolayers was dependent
on size41. Transport of these nanomaterials was found to occur mainly by endocytosis and
smaller lipid nanoparticles exhibited higher permeability41. The attainment of high relative
basolateral/treatment NPPS concentration (> 65%) and the evidence of apparent saturating
transport characteristic at high concentration is suggestive of the involvement of active
transport mechanisms. In a paper evaluating the cellular uptake of chitosan nanoparticles
in Caco-2 cells, the authors reported change from extracellular interaction of chitosan to
cellular internalization via clathrin-mediated endocytosis following nanosization42.
Chitosan nanoparticles were also reported to be internalized via adsorptive endocytosis,
macropinocytosis and caveolae-mediated endocytosis43,44.

Various factors may have influenced the apparent detection of PS or NPPS accumulation
in the basolateral compartment. Firstly, as pointed out earlier in the validation of the model,
the bioassay used for measuring PS and NPPS lacks specificity in that it registers all
immunostimulatory activity. In this regard, the induction of keratinocyte monolayer by
NPPS to produce immunostimulatory factors and the subsequent release into the
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basolateral compartment could lead to an apparent increase in NPPS penetration resulting
in an over-estimation of penetration. Obviously, this is not true for PS as no penetration
was detected. Secondly, the loss of the membrane integrity due to PS or NPPS toxicity
could not be ruled out as we did not assess this parameter at the end of the experiment. This
could have been measured by evaluating the TEER of the monolayer at the conclusion of
the penetration study. As pointed out by Konishi et al., lower integrity of the monolayer
may result in higher permeability of the membrane28. Therefore, the limitations of the
bioassay and experimental design allow for the possibility that nanosizing bulk PS did not
enhance its penetration. Instead, potential NPPS toxicity to the monolayer affected the
viability and disrupted tight junctions thereby affecting its ability to act as a barrier to
NPPS.

Increasing the penetration of a compound across a monolayer clinically translates to
increasing its bioavailability45–47. The monolayer model used in the present study provides
evidence to support the hypothesis that nanosizing PS enhances its penetration across a
membrane barrier. This conclusion is based on assumptions that: (1) there was no cellular
metabolism of PS; (2) NPPS did not affect the integrity of the monolayer, and; (3) NPPS
did not interact with keratinocytes and induce a release of stimulatory factors.

2.3.3 Effect of substrate molecular weight on nanosization
2.3.3.1 Morphology and size distribution of NPPS prepared from ginseng PS of
different molecular sizes.
As mentioned earlier, ginseng PS are quite heterogeneous with molecular weights ranging
from as high as 2,000 kDa to as low as 3.1 kDa48,49. This raises the question of whether this
parameter would influence the responsiveness to the nanosizing process as well as the
quality and biological activity of the resulting NPPS. The other issue is whether the
heterogeneity of the PS sample would be able to facilitate the process. Three different
substrates were obtained by ultrafiltration of PS into three molecular weight sub-fractions:
≥ 100 kDa, 50 - 100 kDa or 30 – 50 kDa. Herein, they will be referred to as sub-fraction L,
M and S, respectively. This separation was based on the pore size specification of
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membranes used in the filtration system (see Fig. 2.3). The average yields for the separation
of bulk PS were as follows: 54%, 27% and 14% for fraction L, M and S, respectively. The
remaining 5 % fraction (< 30 kDa) was not used in the subsequent study. The yield of the
NPPS synthesized from these fractions averaged approximately 94% and similar to the
yield of NPPS prepared using bulk PS.

The size and morphology of the L-NPPS, M-NPPS and S-NPPS were characterized by
TEM (Fig. 2.10i) and then processed by “ImageJ” software (Fig. 2.10ii). TEM image
showed that the nanoparticles obtained from the three sub-fractions were spherical and
monodispersed. As shown in Fig. 2.6ii, the NPPS obtained from the sub-fractions S, M and
L had a mean diameter of 12 nm, 16 nm and 16 nm, respectively. S-NPPS had a relatively
smaller size distribution than other two NPPS – M-NPPS and L-NPPS. In general, the size
of these NPPS was smaller than those prepared from bulk PS (19 nm) (Fig. 2.5)
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ii(a)

i(b)

ii(b)

i(c)

ii(c)

Figure 2.10. (i) Transmission electron microscopy (TEM) and (ii) size distribution of
NPPS prepared using (a) 30-50 kDa, (b) 50-100 kDa and (c) >100 kDa ultracentrifuged PS
fractions. NPPS were synthesized by nanoprecipitation using microfluidics with a 1:20
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flow rate ratio and 0.020-inch PEEK tubing. TEM was performed using Philips CM10 and
acetone as a dispersant. The scale is at 100 nm.

Separation of bulk PS into molecular weight sub-fractions reduces its heterogeneity in
molecular weight. Compared to conventional polymers, PS polymers are not only
heterogeneous due to differences in monomeric repeat number, but also in its composition.
Results revealed that using more homogenous substrates (L-PS < M-PS < S-PS) produced
NPPS with similar yields but with smaller particle sizes compared to using a bulk
heterogeneous PS. Among the NPPS produced from the sub-fractions, the small molecular
fraction resulted in smaller NPPS. It is possible that restricting the heterogeneity of the
substrate enhances the order during nucleation, thereby increasing crystallinity. If the
substrate is more homogenous, it is possible that nucleation of individual PS molecules
during nanoprecipitation would be more uniform because there is less variability in
molecular weight constrained by separation into molecular weight sub-fractions.
Conversely, nucleation of highly heterogeneous PS would result in variable crystallization.
To investigate this claim, further analysis such as X-ray diffraction (XRD) would be
needed to determine crystallinity between fractionated NPPS. Differences in viscosity and
sedimentation velocity between molecular weight fraction of PS may also contribute to the
apparent shift in size. These two factors could potentially influence the agglomeration of
PS.

The influence of polymeric molecular weight on nanomorphology and size has been
reported previously in the literature. Polymeric molecular weight was observed to decrease,
increase or have no effect on particle size in different studies50–52. Although this has been
demonstrated, microfluidic processing of ginseng PS differs in lacking an additional
stabilizer or polymer. Using microfluidics, Akhter et al. demonstrated that similar factors
compared to conventional nanoprecipitation influenced nanoparticle characteristics11.
These factors include the flow-rate of solvents and anti-solvents as well as the water-toacetone ratio11. Our preliminary data (not shown) also indicate that solvent concentration
affects nanoparticle size above the solubility threshold. Part of this was attributed to
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clogging of the pore and build-up in the T-junction by aggregates that form at high
concentrations.

2.3.3.2 Effect of substrate molecular weight on the bioactivity of NPPS.
Following the analysis of the physicochemical property of the three NPPS preparations (L, M- and S-NPPS), we proceeded to examine their immunostimulatory activity to determine
if a relationship existed between these two parameters. Data presented in Fig. 2.11. showed
the 24-hr stimulation of NO production by macrophages. Both PS and NPPS displayed
good dose-dependent effects. As shown in Fig. 2.11, the immunostimulatory potency of
PS was related to the molecular size; the smallest sub-fraction – ‘S’ – was less potent
compared to the M and L fraction. This observation was consistent with previous reports
from Azike et al. and Lemmon et al.6,7. NPPS prepared from these 3 different sub-fractions
showed higher potency than L-, M- and S-PS, indicating the potency enhancing effect of
nanosization; however, there were no significant differences among them. This is
consistent with our previous finding using bulk PS as the substrate which demonstrated
enhanced potency with nanosization (Fig. 2.7.). We have also found that nanosization had
the greatest effect on the smallest fraction, with the largest increase in potency. This may
also suggest that nanosization of a bulk PS sample containing species with a range of
molecular sizes may reduce the heterogeneity of the population in reference to individual
molecules.
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Figure 2.11. Immunostimulatory effects of (i) ginseng PS and (ii) NPPS on the production
of NO by macrophages after 24 hrs. Three molecular weight fractions were used: (a) 3050 kDa (S), (b) 50-100 kDa (M) or (c) >100 kDa fractions (L). RAW 264.7 cells were
treated with 0, 50, 100 or 200 µg/mL of sub-fractionated PS or NPPS for 24 hrs. LPS (1
µg/mL) was used as the positive control; LPS control was used in each figure for better
comparison. Experiments were performed in triplicates and the data are presented as mean
± SEM, n = 3. Data were statistically analysed by one-way ANOVA followed by Dunnett’s
post-hoc test. * Values P < 0.05 compared to the vehicle (zero) control are statistically
significant.

This section focused on the influence of the molecular size of PS on its nanosization into
NPPS. Results of this experiment indicated that PS of different molecular sizes could be
nanosized by microfluidics into more active immunostimulatory NPPS. These NPPS (S,
M and L) exhibited similar bioactivity despite some differences in particle size.
Furthermore, it was demonstrated that microfluidic processing could be applied equally
well to a heterogeneous mixture of PS (i.e., bulk PS) as compared to more homogeneous
sub-fractions (i.e., S-, M- and L-PS). This finding may have implications in designing
future protocols for microfluidics-based nanosization of ginseng PS.

2.4 Conclusions
We have been successful in preparing NPPS from bulk PS substrate by a continuous
microfluidics methodology as described by Akhter et al. with modifications11. This
procedure produced nanoparticles with uniform morphology and narrow size distribution
of ~10-25 nm. The resulting nanoparticles were unimodal spheres, monodispersed and
exhibited low agglomeration compared to the bulk material, ginseng PS.

These NPPS showed enhanced immunostimulatory activity as compared to bulk PS when
tested in cultured RAW 264.7 macrophages. NPPS also demonstrated good penetration
across the keratinocyte monolayer in vitro, while PS showed little, if any, penetration.
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These findings provided critical and corroborating evidence supporting our earlier
observation of the disposition of NPPS, but not PS, in dermal tissues following topical
application in an animal model. Lastly, a study was conducted to investigate the influence
of the molecular size of PS substrates on the production of NPPS by the microfluidicsbased nanoprecipitation procedure. This was essential, as the crude PS used in our study is
known to be heterogeneous, making up of PS of different molecular sizes: ≥ 100 kDa (L),
50 - 100 kDa (M) and 30 – 50 kDa (S), with sub-fraction ‘S’ showing the lowest
immunostimulatory activity. Data showed that all three sub-fractions could be prepared
into nanoparticles with similar yield and comparable enhanced immunostimulatory
activity.

In conclusion, we have been successful in modifying the microfluidics methodology for
the preparation of ginseng NPPS from bulk PS. The characterization study has provided
evidence of well-defined and consistent physicochemical and pharmacological properties;
this data will support its application in the nutraceutical field. However, its fate in
biological tissues and organism is largely unknown. Information is needed to address their
potential toxicity. Future studies should investigate the fate of ginseng NPPS and address
the potential toxicity associated with nanomaterials.
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Chapter 3

Mechanism of macrophage stimulation in
vitro by American ginseng polysaccharides
nanoparticles
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3.1 Introduction
Panax ginseng (Asian ginseng) is a perennial plant that has been traditionally used as a
herbal remedy for the treatment of general malaise, gastrointestinal distress and diseases
of the respiratory system, whereas Panax quinquefolius (North American ginseng) was
primarily used to relieve cold sores, fevers and gastrointestinal distress1,2. The two major
phytochemicals in ginseng are ginsenosides and polysaccharides (PS). Ginseng PS are not
secondary plant metabolites but are part of the cell wall and are released by hydrolysis
during processing. Polysaccharides are large hydrophilic molecules that have diverse
composition, conformation and structure. The PS component consists mainly of starch-like
PS, pectins and hemicellulose, with starch-like PS being the primary carbohydrate
component3.

Ginseng PS are known as adaptogens, which are substances thought to increase
physiological resistance to physical and chemical stress. Adaptogenic effects are nonspecific, and; immunomodulation is one of these adaptogenic effects. Ginseng PS have
been demonstrated in vitro to enhance hydrogen peroxide (H2O2) and nitric oxide (NO)
production of murine peritoneal macrophages4. PS-treated macrophages were also shown
to exhibit stimulated lysosomal phosphatase and phagocytic activities4. In addition,
cytokine production – tumor necrosis factor alpha (TNFα), NO, interleukin (IL)-6 and IL1β – was upregulated in RAW 264.7 macrophages (Abelson murine leukemia virus
transformed macrophages) treated with PS5. Similar upregulation of cytokine production
was observed in mice treated with orally administered PS6. In a recent preclinical study, a
ginseng PS extract was reported to increase T and B lymphocyte proliferation and natural
killer (NK) cell activity in cyclophosphamide-induced immunosuppressed mice7.

North American ginseng roots are marketed as teas, beverages and natural health products
(NHPs). COLD-FX®️ (CVT-E002), which is one of the best-known NHPs in Canada, is
manufactured from NA ginseng as a PS extract enriched in polyfuranosyl-pyranosylsaccharides. Clinical trials revealed that COLD-FX®️ was effective in preventing acute
respiratory illness in immunocompetent seniors8. In a more recent clinical trial, a
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decreasing trend in the incidence of acute respiratory illness in Chronic Lymphocytic
Leukemia patients taking COLD-FX®️ was reported9.

Ginseng PS act by binding to pathogen recognition receptors (i.e., toll-like receptor (TLR)
2/4) which trigger subsequent intracellular pathways resulting in an immune response10,11.
Briefly, dimerization of TLR4 mediates the activation of the nuclear factor-kappa-lightchain-enhancer of activated B cells (NF-κB) cascade downstream12. Consequently, the
production of TNFα, IL-6, IL-1β and NO are upregulated, to name a few13,14. In addition
to the NF-κB cascade, ERK-1/2, PI3K and p38 pathways have been implicated in the
immunomodulatory effects of ginseng PS15. Following TLR activation, cell-surface TLRs
are internalized, which reduces the responsiveness of immune cells to TLR agonists16,17.
The TLRs are endocytosed as a complex with the TLR ligand, which may be mediated by
cluster of differentiation 14 (CD14)17,18. This is commonly known as TLR desensitization
or TLR tolerance in macrophages. Animal lectins that can recognize and bind
carbohydrates are another potential receptor for ginseng PS19. These potential mechanisms
of activation of PS may differ following microfluidic processing to synthesize
nanoparticles of ginseng PS (NPPS).
Nanoparticles are particles with at least one-dimension that ranges from 1 – 1000 nm. They
are surrounded by a surface/interfacial layer, which is the “region intermediate between
two bulk phases in contact”20. This region may or may not contain other inorganic materials
or ions, depending on the methodology used to prepare them. Nanotechnology is often
applied to compounds that are poorly soluble and large in size to produce nanoparticles
while controlling these properties21,22. Nanoparticles typically exhibit size-related
properties different from their substrate compound23,24. They have been shown to have
higher permeability than the drug or substrate that was used to prepare them25. The
enhanced permeability is generally attributed to the reduction in particle size and alteration
of surface chemistry (ex. polarity, solubility, etc.)22,24,26.

NPPS possess different potencies than its substrate, in addition to different
physicochemical properties. Bulk PS are present in solution as large micron-sized particles
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and agglomerates whereas NPPS have a uniform and spherical nanomorphology. These
NPPS have exhibited greater immunostimulatory activity (NO, TNFα, IL-6) in vitro
relative to regular ginseng PS (i.e., bulk PS)6. Ginseng NPPS have been shown to correlate
with greater NO and cytokine (TNF-α) levels in murine blood samples collected by cardiac
puncture following oral gavage6. In addition, higher levels of IL-1β, TNF-α and NO in
blood serum and skin samples have also been reported in hairless mice topically treated
with ginseng NPPS6. Previous research indicated that ginseng NPPS accumulated within
the macrophages with no apparent retention at the cell membrane and showed earlier
intracellular uptake6. On the other hand, ginseng PS was retained at the cellular membrane6.
Although NPPS appeared to exhibit higher immunostimulatory activity and showed
enhanced cellular uptake; the underlying mechanism is poorly understood. Accordingly,
the present study has been conducted to test the hypothesis that NPPS do not share the
same cellular mechanism in mediating its immunostimulatory action as compared to PS.
In order to do this, we examined the role of TLRs by i) defining the time-course of
macrophage activation; ii) assessing the influence of TLR desensitization by LPS; and iii)
suppression of activation by selective TLR antagonist. Our data showed that in contrary to
our hypothesis, NPPS behaved like PS under these experimental conditions.

3.2 Experimental Procedure
3.2.1 Materials
Ginseng PS were extracted and isolated from aqueous extract of Panax quinquefolius
which was provided by the Ontario Ginseng Innovation and Research Consortium.
Deproteinated PS (i.e., bulk PS) was used to synthesize ginseng NPPS by nanoprecipitation
using microfluidics (Fig. 2.1)27. Subsequently, the resulting nanomaterials were
characterized for its physicochemical properties (Ch. 2.2.) prior to performing
pharmacological studies on ginseng NPPS.

Abelson murine leukemia virus transformed macrophages (RAW 264.7) (ATCC TIB 67)
provided by Dr. Jeff Dixon (Department of Physiology and Pharmacology, University of
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Western Ontario, Canada) were used for pharmacological studies. Dulbecco’s Modified
Eagle’s Medium (DMEM) and Fetal Bovine Serum (FBS) (US origin) were purchased
from Gibco laboratories (USA). Lipopolysaccharides from Escherichia coli (O111:B4),
Sparstolonin B (SsnB) and Griess’ reagent (modified) were purchased from Sigma-Aldrich
(Canada).
3.2.2 Macrophage cell culture and marker of activation
RAW 264.7 were cultured in DMEM supplemented with 10% Fetal Bovine Serum (FBS)
and 1% penicillin/streptomycin. Cell cultures were maintained at 37 ℃ in a humidified
incubator with 10% CO2. The concentration of CO2 was used in accordance with the
concentration of sodium bicarbonate (3.7 g/L) within the media to maintain a pH of ~ 7.4.
RAW 264.7 cells were passaged every 3-4 days at approximately 80% confluency. Cell
culture media were changed one day prior to passaging. Cell cultures were tested for
mycoplasma contamination and were negative for contamination. For experiments, RAW
264.7 cells were seeded in 96-well tissue culture plates at a density of 1.5 x 105 cells per
well and incubated at 37 ℃ and 10% CO2.

The marker of macrophage activation was the induction of iNOS, which was assessed by
measuring NO production via colorimetric detection of the presence of nitrite ions in the
media. Nitrite is a final product of the NO oxidation pathway. Nitrite was quantified using
a modified Griess’ reagent containing 0.5% sulfanilic acid, 0.002% N-1-naphthylethylenediamine dihydrochloride and 14% glacial acetic acid (Sigma-Aldrich, USA).
Briefly, 50 µL of Griess’ reagent was added to 50 µL of culture supernatant and incubated
away from light at room temperature for 15 mins. Absorbance at 540 nm wavelength was
measured using uQuant microplate reader (Biotek Inc.). Nitrite concentrations in samples
were estimated from the standard curve prepared by dilutions of sodium nitrite.
3.2.3 Time-course of immunostimulation
To determine the onset of action, RAW 264.7 cells were treated with 200 µg/mL of PS or
NPPS for 6, 9, 12, 15, 18, 21 or 24 hrs. Macrophage response to PS or NPPS was
determined by measuring the NO level in the culture supernatant.
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3.2.4 Effect of TLR desensitization by LPS pre-treatment
To determine whether NPPS act via binding to TLRs and followed by internalization (i.e.,
translocation), a model of LPS-induced desensitization of macrophage responsiveness via
treatment-induced internalization of TLRs was used. This model was set-up by pre-treating
cultured RAW 264.7 cells with 1 µg/mL of LPS or vehicle control (media) for 24 hrs to
induce TLRs internalization. Following pre-treatment, LPS-challenged macrophages were
washed three times with PBS to remove the remaining LPS. Cells were subsequently
treated with 50 and 200 µg/mL of ginseng PS or NPPS. LPS (1 µg/mL) was used as the
positive control. At 24 hrs, cell culture supernatant was removed. The end-point was 24
hrs NO production by macrophages.
3.2.5 Effect of pre-treatment with a selective inhibitor of TLR 2/4 (Sparstolonin B)
To determine the role of cell surface toll-like receptors in the mediation of NPPS activity,
SsnB, a selective TLR2/4 antagonist, was used to inhibit downstream TLR signalling in
cultured macrophages28. For this, cultured RAW 264.7 cells were treated with or without
SsnB (10 µg/mL and 100 µg/mL). Cells were treated concurrently with ginseng PS or
NPPS (200 µg/mL). At 24 hrs, cell culture supernatant was removed for determination of
24 hrs NO accumulation.
3.2.6 Statistical analysis
Data are present as mean ± standard error of the mean (SEM). The two-way analysis of
variance (ANOVA) followed by Bonferroni’s post hoc test was used for the comparison of
means between treatment groups. Statistical analysis was performed using GraphPad Prism
6 software (San Diego, CA). Values P<0.05 compared between treatment groups were
considered statistically significant.
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3.3 Results and Discussion
3.3.1 Time-course of immunostimulatory effect of PS and NPPS in macrophages in
vitro
To investigate if NPPS and PS have a different mechanism of action, the onset of
immunostimulation in vitro was studied. This was studied by treating cultured
macrophages with bulk PS or NPPS for 24 hrs and examined the response in 3-hr intervals.
Bulk PS treatment induced significant NO production over control values beginning at ~
15 hrs (Fig. 3.1). Nitric oxide production from PS stimulation reached plateau at ~ 18 hrs.
On the other hand, the earliest significant increase in NO production with NPPS was
observed at ~ 12 hrs; and maximum stimulation was noted at ~ 15 hr. In summary,
compared to bulk PS treatment, NPPS treatment elicited a greater maximal response in
macrophages and had an earlier onset.

*

*

*

*

*

*
*

**
*

Figure 3.1. Immunostimulatory effects of ginseng PS and NPPS on macrophage nitrite
production. Stimulation of RAW 264.7 macrophages by ginseng PS or NPPS. RAW 264.7
cells were treated with 200 µg/mL of PS and NPPS for 6-24 hrs. Three independent
experiments were performed in triplicates and the data are presented as mean ± SEM.
Datasets were statistically analysed by two-way ANOVA followed by Bonferroni’s post
hoc test. * Values P < 0.05 compared to time zero (i.e., control) are statistically significant.
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The observed time-course of action of NO production is consistent with the reported
activation of the TLR-dependent NF-κB signalling pathway induced by pathogen
associated molecular patterns (PAMPs). Jacobs et al. also reported a similar finding
pertaining to LPS induced iNOS protein response in RAW 264.7 cells29. In this study,
detectable levels of NO with NPPS and PS treatment groups were observed at ~ 9 hrs.
Consistent with our results, NO production rate was reported by Jacobs et al. to reach
steady-state levels at ~ 9 hrs before reaching maximum plateau29. For NPPS-treated
macrophages, NO levels increased linearly until a maximum plateau at approximately 15
hrs following treatment, similar to the time taken to reach the plateau phase observed by
He et al.30. In addition, we have previously determined that ginseng extracts can elicit
optimal stimulation at approximately 24 hrs. The significance of the earlier onset of action
associated with NPPS treatment (Fig. 3.1.) is not clear; however, this appears to support
the earlier cellular uptake of NPPS compared to PS as determined by bioimaging using
RAW 246.7 macrophages6. The observed difference in time-course of action between
NPPS and PS suggests that NPPS may not mediate its cellular activation by the activation
of TLR signalling pathway that has been well established for PS. Some nanomaterials have
been shown to penetrate the cell which allows for the activation of intracellular
mechanisms31–33.
3.3.2 Immunostimulatory effects of NPPS in LPS-desensitized macrophages in vitro
To determine the involvement of the TLR signalling pathway in mediating the action of
NPPS, we desensitized macrophages with prior LPS treatment for 24 hrs to induce TLR
internalization. These cells were then challenged with 0, 50 or 200 µg/mL of PS or NPPS
treatment to assess their responsiveness. LPS were used as the positive control to establish
standard cellular responsiveness. NO production was measured as a basis for macrophage
responsiveness to LPS, PS or NPPS. As shown in Fig. 3.2, pre-treating macrophages with
LPS reduced the macrophage response to subsequent LPS stimulation by ~ 48%. This
finding is consistent with our earlier report5. The observed reduction in responsiveness is
believed to be a result of the reduced presence of cell-surface TLRs and the attenuation of
responsiveness to TLR agonists17,34. A study by Rajaiah et al. showed that the induction of
tolerance by exposure of macrophages to LPS induced TLR4 endocytosis18. The apparent
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LPS-induced loss of responsiveness was not due to artifacts resulting from additional 24hr incubation since pretreatment with the vehicle did not alter the macrophage
responsiveness. Additionally, the response to PS and NPPS in macrophages pretreated with
the vehicle for 24 hr showed good dose-dependency and was comparable to what we
reported in Chapter 2 for regular (non-treated) macrophages (Fig. 2.4). Data presented in
Fig. 3.2 also showed that LPS-pretreatment reduced the responsiveness to both levels of
PS and NPPS challenges by 33 to 50%. This finding suggested that NPPS like PS is an
agonist of TLR in view of their sensitivity to LPS-induced desensitization. However, it
should be noted that because the LPS-induced desensitization on NPPS and PS was less
than 50%, our data could not rule out the participation of other mechanism(s).

Vehicle Pre-treatment

Nitrite
(μM)
Production (μM)
Nitrite Production

LPS Pre-treatment

Figure 3.2. Immunostimulatory effects of ginseng PS and NPPS on macrophage NO
production. RAW 264.7 cells were pretreated with vehicle or LPS (1 µM) for 24 hrs prior
to treatment with 200 µg/mL of NPPS or PS for 24 hrs. LPS was used as a positive control
to evaluate cellular responsiveness. Experiments were performed in triplicates and the data
are presented as mean ± SEM, n =3. Data were statistically analysed by two-way ANOVA
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followed by Bonferroni’s post hoc test. *Values P < 0.05 compared between pre-treatments
are statistically significant.
3.3.3 TLR 2/4 antagonist suppressed NPPS activity
To further ascertain whether TLR2/4 are involved in the mediation of NPPS activity, a
selective antagonist (SsnB) was used to inhibit the recruitment of myeloid differentiation
primary response 88 (MyD88) to TLR2/4 in macrophages, which is a critical step in the
activation process. As expected with PS, the presence of SsnB significantly reduced PSmediated NO production by macrophages (Fig. 3.3). The degree of inhibition was related
to concentration of the antagonist: 10 µg/mL and 100 µg/mL SsnB, induced a ~ 60% and
~ 98% reduction, respectively. A similar concentration-dependent SsnB induced reduction
of NPPS-mediated NO production by macrophages was also observed.

Sparstolonin B is a novel compound isolated from Sparganium stoloniferum that has been
demonstrated to inhibit signalling pathways (i.e., MAPK and NF-κB) downstream of
TLR2/4 activation. Considerable evidence suggests the presence of SsnB intracellularly
inhibits the ligand-induced association of MyD88 to TIR-domain-containing adaptor
protein (TIRAP) and TLR2/4 complex28. Therefore, a reduction in the macrophage
response to TLR2/4 agonists is expected as a result of the reduced MyD88 association.
Together with the purported SsnB antagonistic activity, these lines of evidence suggest that
ginseng NPPS, like PS, act on TLR2/4 signalling. Furthermore, the marked suppression of
NPPS action in the presence of a selective TLR 2/4 antagonist observed in this experiment
strongly implicates the involvement of the TLR pathway in mediating the
immunostimulatory action of NPPS. In addition, in light of the known mechanism of
action of the antagonist used, the site of action of NPPS and bulk PS could be narrowed
down to a site in the TLR4 signalling upstream of ligand-induced MyD88 association.
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Figure 3.3. Immunostimulatory effects of ginseng PS and NPPS on macrophage NO
production over a 24-hr period. RAW 264.7 cells were treated in the presence of 10 or 100
µg/mL SsnB and, with 200 µg/mL of PS or NPPS for 24 hrs. Treatment with PS or NPPS
in the absence of SsnB were the negative controls. Experiments were performed in
triplicates and the data are present as mean ± SEM, n =3. Data were statistically analysed
by two-way ANOVA followed by Bonferroni’s post-hoc test. *Values P < 0.05 compared
with the negative control within the treatment group are statistically significant.

Ginseng and other plant PS have been reported to activate TLR2 or TLR4 signalling. For
example, Agaricus brasiliensis beta-glucans has recently been shown to enhance
phagocytic activity of monocytes via TLR2/4 signalling35. In another study, ginseng PS
immunostimulation was impaired in TLR4 deficient mice (C2H/HeJ)36. TLR2 and TLR4
have also been implicated in the response of mammary glands treated with ginseng
extracts37. Shin et al. reported that CD14 was upregulated in macrophages treated with a
ginseng PS preparation (i.e., ginsan), which implicates CD14 in PS activation of
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macrophages10. A contemporary study showed that smaller chains of ginseng PS activate
TLR2 as opposed to TLR411. Therefore, ginseng PS may be directly binding to CD14 or
TLR2/4 to elicit a response. Our data suggest that both NPPS and PS may mediate
macrophage response via TLR signalling; however, it is not certain whether the molecular
mechanism of PS could be extended to NPPS. This question should be addressed by taking
into consideration that microfluidics processing was demonstrated to not functionally alter
ginseng PS, but rather alter surface chemistry.

The activation of TLR signalling by NPPS may be through binding to CD14 or directly to
TLR2/4. The binding to CD14 has been studied with reference to LPS 38,39. This usually
involves the interaction of LPS aggregates to CD14, which catalyzes its monomerization
prior to presentation to TLR439,40. Based on their data, Kitchens et al. proposed that
monomeric LPS-CD14 complexes are necessary to elicit a response38. Similarly, ginseng
PS exists in aqueous solution as aggregates. It is not certain how NPPS, which has a smaller
particle size than PS, would behave under this condition. However, it is possible that
ginseng PS and NPPS also require monomerization by CD14 and presentation to TLR4.
Ginseng NPPS may also be more potent than PS due to the smaller apparent size of its
agglomerates. This is supported by the report that aggregates of LPS are less potent when
their aggregates sizes were increased41. With this consideration, we propose that
nanosization enhances binding affinity through the reduction in particle size.

The observation that NPPS stimulated macrophages earlier and to a greater extent than
bulk PS suggested the possibility of a different mechanism of activation between NPPS
and bulk PS. Alternatively, NPPS may be acting via similar mechanism(s) as bulk PS but
act faster and more efficiently to achieve high maximum response. Higher receptor affinity
or involvement of accessory proteins are possible explanations for this speculation.
Partially reduced responsiveness was observed following LPS-desensitization in both
NPPS and PS conditions. This suggested that they may share the same pathway of
activation; although, they may still act differently at certain levels (e.g., CD14). The
observed reduction could also be the result of non-specific effects of LPS. The hypothesis
that NPPS act differently than bulk PS was refuted by the activation of TLR signalling by
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the nanoparticles, but the possibility of a different mechanism should not be entirely
discarded. It is possible that additional mechanism(s) may exist in conjunction with TLR
activation, or other mechanism(s) of activation by PS such as animal lectins have been lost
following nanonization. Further studies are needed to determine other potential receptors
of NPPS. Despite this, the results of this experiment have enabled us to begin to elucidate
the basis behind the enhancement of PS’ stimulatory effect following nanonization.

Alternative pathways for NPPS activation of macrophages could be examined in future
studies. Other potential receptors for ginseng PS are complement receptor-3 (CR3),
scavenger receptor (SR), dectin-1 and mannose receptors, which have been demonstrated
to bind to carbohydrates and are implicated in the activation of the NF-kB pathway in
macrophages19,42. Dectin-1 and mannose receptors are animal lectins (carbohydratebinding proteins) that have high specificity for sugar moieties19. Dectin-2, galectins and
immunoglobulin-like lectins are other animal lectins that have been implicated in the
immunostimulatory activity of botanical polysaccharides19.

3.4 Conclusions
The objective of this chapter was to investigate the mechanism of immunostimulation
exerted by NPPS that was prepared by microfluidic processing from ginseng PS. The
strategy was to define the time-course of action in cultured macrophages and to determine
whether NPPS shared a different mechanism as PS and LPS. Our data showed that NPPS
has a faster onset of action and a higher maximum response than PS, which corroborated
with the bioimaging data from our previous study using macrophages. Using an LPSinduced desensitization model involving increased TLR internalization and downstream
negative regulation of TLR signalling, we showed that TLR-dependent pathway was
involved – at least in part – in the mediation of action of NPPS and PS. Furthermore, the
successful suppression of NPPS and PS-induced immune response with the selective
TLR2/4 antagonist, SsnB, has provided evidence to identify a site in the TLR4 signalling
upstream of ligand-induced MyD88 association. It is likely that NPPS act similar to
ginseng PS in activating TLR-mediated NF-κB signalling; however, it remains to be
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determined whether other mechanism(s) may be involved and the basis underlying the
more rapid onset and higher potency of NPPS.
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Chapter 4
Conclusions and Recommendations
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4.1 Summary and conclusions
4.1.1 General objectives
In this project, two primary objectives have been addressed pertaining to the conversion of
ginseng PS to their nanoparticle form by microfluidics: (1) modification of the existing
microfluidics methodology for NPPS synthesis and characterization of their
physicochemical and pharmacological properties; and (2) investigation of mechanism(s)
underlying the immunostimulatory activity of nanoparticles to provide insight into the
cellular action and target(s) of NPPS.

4.1.2 Modification of microfluidics methodology
Modification of the microfluidics procedure developed by Akhter et al. has provided
information regarding its limitations and undefined variables (i.e., substrate concentration).
The main limitations associated with the previously reported methodology are low total
yield and susceptibility to poor sample recovery. Based on the physicochemical
characterization data, we could conclude that the modified microfluidic methodology was
able to produce NPPS from bulk PS with a reasonable yield of approximately 95 %, and a
size distribution averaged around 19 nm. The NPPS exhibited monodispersed and spherical
nanomorphology, which is characteristic of previously synthesized NPPS.

4.1.3 Biological and physicochemical characterization of NPPS
Biological characterization of the resulting NPPS revealed that microfluidic processing of
bulk PS enhanced its immunostimulatory activity in vitro. Data from this experiment
assisted in the development of a novel macrophage-based bioassay for PS and NPPS
quantitation in order to address the lack of plant PS quantitation technology. Furthermore,
coupling a keratinocyte monolayer model with the macrophage-based bioassay has
provided a new in vitro system to assess bioavailability. By utilizing this system, we were
able to study the transport of PS and NPPS across a cellular membrane barrier. Moreover,
this approach reduces the number of experimental animals needed for initial screening
purposes.
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Using this novel technology, we have demonstrated that NPPS showed significant
penetration across an established keratinocyte monolayer that acts as an effective barrier
for bulk PS. These findings provided insight into the potential relationship between reduced
particle size and enhanced permeability of ginseng NPPS.

While investigating the relationship between substrate molecular weight and the
characteristics of NPPS, we were able to conclude that molecular size of the PS substrate
influenced the physicochemical property and immunostimulatory potency of NPPS.
However, findings revealed that nanosizing enhanced the potency of lower molecular
weight bulk PS, which exhibited lower immunostimulatory potency relative to the higher
molecular weight PS.

4.1.4 Mechanism of macrophage activation by NPPS
The mechanistic study of ginseng NPPS reported in Ch. 3 demonstrated reduced
responsiveness of desensitized-macrophages to NPPS and impaired NPPS-induced
response in macrophages treated together with an antagonist. Results from this study
demonstrated the importance of TLR2/4 signaling in NPPS activation of macrophages and
supports the conclusion that NPPS behave like ginseng PS. Taken together with the
physicochemical prosperities of NPPS, these findings have allowed us to conclude that
nanonization of bulk PS does not alter its ability to activate TLRs.

4.2 Challenges and solutions
The low sensitivity and specificity of the biological assay for PS and NPPS estimation of
concentration is one of the major challenges associated with our study. To address this
issue, we have proposed to develop a more sensitive and specific measurement of cellular
marker for immunomodulation using new biotechnology such as cytokine gene expression.
This would be advantageous for the detection of immunostimulatory responses to low
concentrations of PS and NPPS, thereby allowing us to estimate sample concentration with
higher sensitivity. Using labelled PS and NPPS is another alternative to measure PS and
NPPS concentration.
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Another major challenge is the lack of tools for PS and NPPS bioimaging. To address this,
we propose the development of quantum-dot labelling-technology for ginseng PS that
would allow for quantification, tracking and detection under in vivo and in vitro conditions.
In addition, it would be beneficial to develop an innovative labelling methodology that is
based on quantum dot technology.

4.3 Future studies
Looking at the project holistically, we suggest studying the structure-activity relationship
between NPPS physicochemical characteristics and ginseng PS immunomodulatory effect
to expand our understanding in this field. Elucidation of this relationship would offer
helpful insight in determining why NPPS are more potent than bulk PS. In addition, it is
important to investigate why NPPS exhibited higher immunostimulatory potency through
more in-depth mechanistic studies.

We did not have the opportunity to investigate potential toxicity of NPPS in vivo, thus,
further investigation on the disposition, pharmacology and safety of NPPS in a biological
system is necessary. Furthermore, NPPS sub-cellular localization, translocation and
transcription site in macrophages have not been defined. Detailed bioimaging would be
very useful to define how NPPS exert their effect as well as their fate in macrophages.
These follow-up studies would enable the development of innovative and safe
nutraceuticals.

The interaction and fate of NPPS with keratinocytes have not been previously addressed.
Keratinocytes were used as a model in this current study to assist in the physicochemical
characterization of NPPS. Therefore, as a follow-up study, examining the response of
keratinocytes following NPPS treatment would assist in developing a more specific
biological assay and determining toxicity. In addition, using bioimaging would be helpful
in addressing its transport and fate in keratinocytes. Alternatively, using fluorescent
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markers for various proteins associated with endosomes would expand our understanding
of the transport of these nanomaterials.

Other potential receptors of ginseng PS (e.g., animal lectins) have been identified in the
literature; however, their implications have not been fully understood. Therefore, it would
be helpful to determine alternative mechanisms of activation by ginseng PS and its
nanoparticle counterpart. These findings would support or oppose the claim that
nanoparticle synthesis does not alter or introduce new activation pathways of bulk PS.
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A.1. Bioassay standard curves.

Figure A.1. Standard curve for biological assay of (a) ginseng PS and (b) NPPS. Twentyfour-hour macrophage stimulation of NO production with 50-300 µg/mL of ginseng PS
and NPPS.
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